<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39186777</article-id><article-id pub-id-type="pmc">11346958</article-id>
<article-id pub-id-type="doi">10.1371/journal.ppat.1012459</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-24-00016</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Spleen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Brucella</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Brucella</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Brucella</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Animal Studies</subject><subj-group><subject>Experimental Organism Systems</subject><subj-group><subject>Model Organisms</subject><subj-group><subject>Mouse Models</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Model Organisms</subject><subj-group><subject>Mouse Models</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Animal Studies</subject><subj-group><subject>Experimental Organism Systems</subject><subj-group><subject>Animal Models</subject><subj-group><subject>Mouse Models</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Disease Control</subject><subj-group><subject>Vaccines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Bacterial Diseases</subject><subj-group><subject>Brucellosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Tropical Diseases</subject><subj-group><subject>Neglected Tropical Diseases</subject><subj-group><subject>Brucellosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Zoonoses</subject><subj-group><subject>Brucellosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Mutagenesis and Gene Deletion Techniques</subject><subj-group><subject>Deletion Mutagenesis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Mutagenesis and Gene Deletion Techniques</subject><subj-group><subject>Deletion Mutagenesis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Gene Prediction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genome Analysis</subject><subj-group><subject>Gene Prediction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Disease Control</subject><subj-group><subject>Vaccines</subject><subj-group><subject>Attenuated Vaccines</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Genome-wide analysis of <italic toggle="yes">Brucella melitensis</italic> growth in spleen of infected mice allows rational selection of new vaccine candidates</article-title><alt-title alt-title-type="running-head">Essential genes of <italic toggle="yes">Brucella</italic> in vivo</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Barbieux</surname><given-names>Emeline</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Potemberg</surname><given-names>Georges</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Stubbe</surname><given-names>Fran&#xE7;ois-Xavier</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fraikin</surname><given-names>Audrey</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Poncin</surname><given-names>Katy</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Reboul</surname><given-names>Angeline</given-names></name><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rouma</surname><given-names>Thomas</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Z&#xFA;&#xF1;iga-Ripa</surname><given-names>Amaia</given-names></name><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>De Bolle</surname><given-names>Xavier</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="econtrib001" ref-type="author-notes">
<sup>&#x2021;</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1250-5228</contrib-id><name><surname>Muraille</surname><given-names>Eric</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="econtrib001" ref-type="author-notes">
<sup>&#x2021;</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Unit&#xE9; de Recherche en Biologie des Microorganismes (URBM)-Laboratoire d&#x2019;Immunologie et de Microbiologie, NARILIS, University of Namur, Namur, Belgium</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Laboratoire de Parasitologie, and ULB Center for Research in Immunology (U-CRI), Universit&#xE9; Libre de Bruxelles, Gosselies, Belgium</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Unit&#xE9; de recherche en physiologie mol&#xE9;culaire (URPhyM)-Laboratoire de G&#xE9;n&#xE9;tique mol&#xE9;culaire (G&#xE9;Mo), University of Namur, Namur, Belgium</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Departamento de Microbiolog&#xED;a y Parasitolog&#xED;a - IDISNA, Universidad de Navarra, Pamplona, Spain</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Roden</surname><given-names>Richard B.S.</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Johns Hopkins University School of Medicine, UNITED STATES OF AMERICA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x2021; These authors contributed equally to this work as last authors.</p></fn><corresp id="cor001">* E-mail: <email>emuraille@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2024</year></pub-date><volume>20</volume><issue>8</issue><elocation-id>e1012459</elocation-id><history><date date-type="received"><day>3</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>29</day><month>7</month><year>2024</year></date></history><permissions><copyright-statement>&#xA9; 2024 Barbieux et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Barbieux et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ppat.1012459.pdf"/><abstract><p>Live attenuated vaccines (LAVs) whose virulence would be controlled at the tissue level could be a crucial tool to effectively fight intracellular bacterial pathogens, because they would optimize the induction of protective immune memory while avoiding the long-term persistence of vaccine strains in the host. Rational development of these new LAVs implies developing an exhaustive map of the bacterial virulence genes according to the host organs implicated. We report here the use of transposon sequencing to compare the bacterial genes involved in the multiplication of <italic toggle="yes">Brucella melitensis</italic>, a major causative agent of brucellosis, in the lungs and spleens of C57BL/6 infected mice. We found 257 and 135 genes predicted to be essential for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> multiplication in the spleen and lung, respectively, with 87 genes common to both organs. We selected genes whose deletion is predicted to produce moderate or severe attenuation in the spleen, the main known reservoir of <italic toggle="yes">Brucella</italic>, and compared deletion mutants for these genes for their ability to protect mice against challenge with a virulent strain of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic>. The protective efficacy of a deletion mutant for the <italic toggle="yes">plsC</italic> gene, implicated in phospholipid biosynthesis, is similar to that of the reference Rev.1 vaccine but with a shorter persistence in the spleen. Our results demonstrate that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> faces different selective pressures depending on the organ and underscore the effectiveness of functional genome mapping for the design of new safer LAV candidates.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><p>Brucellosis is one of the most widespread bacterial zoonoses worldwide. We report here the use of transposon sequencing to compare the bacterial genes involved in the multiplication of <italic toggle="yes">Brucella melitensis</italic>, a major causative agent of brucellosis, in the lungs and spleens of infected mice. We found 257 and 135 genes predicted to be essential for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> multiplication in the spleen and lung, respectively, with 87 genes common to both organs, which demonstrates that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> faces different selective pressures depending on the organ. Then, we selected genes whose deletion is predicted to produce moderate or severe attenuation in the spleen, the main known reservoir of <italic toggle="yes">Brucella</italic>, and compared deletion mutants for these genes for their ability to protect mice against challenge with a virulent strain of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic>. We observed that the protective efficacy of a deletion mutant for the <italic toggle="yes">plsC</italic> gene, implicated in phospholipid biosynthesis, is similar to that of the reference Rev.1 vaccine but with a shorter persistence in the spleen. Our results demonstrate the effectiveness of functional genome mapping for the design of new safer live attenuated vaccine candidates.</p></abstract><funding-group><award-group id="award001"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002661</institution-id><institution>Fonds De La Recherche Scientifique - FNRS</institution></institution-wrap>
</funding-source><award-id>CDR J.0120.18</award-id><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1250-5228</contrib-id>
<name><surname>Muraille</surname><given-names>Eric</given-names></name>
</principal-award-recipient></award-group><award-group id="award002"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002661</institution-id><institution>Fonds De La Recherche Scientifique - FNRS</institution></institution-wrap>
</funding-source><award-id>CDR J.0157.20</award-id><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1250-5228</contrib-id>
<name><surname>Muraille</surname><given-names>Eric</given-names></name>
</principal-award-recipient></award-group><award-group id="award003"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002661</institution-id><institution>Fonds De La Recherche Scientifique - FNRS</institution></institution-wrap>
</funding-source><award-id>PDR T.0058.20</award-id><principal-award-recipient>
<name><surname>De Bolle</surname><given-names>Xavier</given-names></name>
</principal-award-recipient></award-group><award-group id="award004"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002661</institution-id><institution>Fonds De La Recherche Scientifique - FNRS</institution></institution-wrap>
</funding-source><award-id>FRIA PhD grant</award-id><principal-award-recipient>
<name><surname>Barbieux</surname><given-names>Emeline</given-names></name>
</principal-award-recipient></award-group><award-group id="award005"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002661</institution-id><institution>Fonds De La Recherche Scientifique - FNRS</institution></institution-wrap>
</funding-source><award-id>FRIA PhD grant</award-id><principal-award-recipient>
<name><surname>Potemberg</surname><given-names>Georges</given-names></name>
</principal-award-recipient></award-group><award-group id="award006"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100002661</institution-id><institution>Fonds De La Recherche Scientifique - FNRS</institution></institution-wrap>
</funding-source><award-id>FRIA PhD grant</award-id><principal-award-recipient>
<name><surname>Stubbe</surname><given-names>Fran&#xE7;ois-Xavier</given-names></name>
</principal-award-recipient></award-group><funding-statement>This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS) (CDR J.0120.18 and CDR J.0157.20 to E.M. and PDR T.0058.20 to X.D.B., Belgium). E.M. is a Senior Research Associate from the FRS-FNRS (Belgium). E.B., G.P. and F-X.S. hold FRIA PhD grants from the FRS-FNRS (Belgium). The funders played no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript.</funding-statement></funding-group><counts><fig-count count="12"/><table-count count="0"/><page-count count="29"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>We have shared the fastq files containing reads from our Tn-seq analyzes on the Figshare site (available at <ext-link xlink:href="https://doi.org/10.6084/m9.figshare.26063158.v1" ext-link-type="uri">https://doi.org/10.6084/m9.figshare.26063158.v1</ext-link>). All of the results of our transposon sequencing analyzes are available in <xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref> which is submitted with the manuscript.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>We have shared the fastq files containing reads from our Tn-seq analyzes on the Figshare site (available at <ext-link xlink:href="https://doi.org/10.6084/m9.figshare.26063158.v1" ext-link-type="uri">https://doi.org/10.6084/m9.figshare.26063158.v1</ext-link>). All of the results of our transposon sequencing analyzes are available in <xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref> which is submitted with the manuscript.</p></notes></front>
  <body>
    <sec sec-type="intro" id="sec001">
      <title>Introduction</title>
      <p><italic toggle="yes">Brucellae</italic> are small Gram-negative facultative intracellular bacteria belonging to the Rhizobiales order within the &#x3B1;2-proteobacteria subgroup [<xref rid="ppat.1012459.ref001" ref-type="bibr">1</xref>,<xref rid="ppat.1012459.ref002" ref-type="bibr">2</xref>]. They are the causative agent of brucellosis, a common bacterial zoonotic disease responsible for important economic losses and public health issues, particularly in low- and middle-income countries [<xref rid="ppat.1012459.ref003" ref-type="bibr">3</xref>&#x2013;<xref rid="ppat.1012459.ref006" ref-type="bibr">6</xref>]. <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> is the species most often involved in ovine and caprine brucellosis and is also the most pathogenic species for humans [<xref rid="ppat.1012459.ref007" ref-type="bibr">7</xref>].</p>
      <p>Due to the impact of this disease on public health and the damage that it causes to the livestock industry, much effort has been expended to control or eradicate brucellosis in cattle and small ruminants. Three commercially available live attenuated vaccines (LAVs) are used to control <italic toggle="yes">Brucella</italic> infection in domestic animals: <italic toggle="yes">B</italic>. <italic toggle="yes">abortus</italic> S19 and RB51 to prevent brucellosis in cattle, and <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> Rev.1 to protect sheep and goats. While the effectiveness of RB51 is controversial [<xref rid="ppat.1012459.ref008" ref-type="bibr">8</xref>], S19 and Rev1 have been used in livestock wherever eradication has been successful. However, both vaccines have serious drawbacks [<xref rid="ppat.1012459.ref008" ref-type="bibr">8</xref>&#x2013;<xref rid="ppat.1012459.ref011" ref-type="bibr">11</xref>]. Their attenuation was obtained empirically, and even accidentally for S19, which makes their virulence quite unpredictable. In some cases, they persist for years in the vaccinated host, where they can induce abortions and excretion in milk in animals, posing a high risk to humans for whom they are virulent [<xref rid="ppat.1012459.ref012" ref-type="bibr">12</xref>]. Since in low- and middle-income regions mass vaccination is the only way to control the disease, which implies vaccination of pregnant animals, the control of brucellosis is therefore more complicated in these areas [<xref rid="ppat.1012459.ref013" ref-type="bibr">13</xref>]. To encourage research in this area, the Bill and Melinda Gates foundation has offered a large prize to reward any new brucellosis vaccine that presents a safer profile.</p>
      <p>The development of safer vaccines should involve functional mapping of the <italic toggle="yes">Brucella</italic> genome to identify the virulence genes that are essential at the different stages of <italic toggle="yes">Brucella</italic> infection in animals. This would allow for the rational development of a vaccine that persists just long enough in the host to induce frontline and systemic protective immune memory but does not remain long term in the reservoir organs.</p>
      <p>Transposon sequencing (<bold>Tn-seq</bold>) is a powerful approach to rapidly and comprehensively determine an organism&#x2019;s minimal genetic requirements for growth and survival under a variety of different conditions [<xref rid="ppat.1012459.ref014" ref-type="bibr">14</xref>,<xref rid="ppat.1012459.ref015" ref-type="bibr">15</xref>]. Previously, we performed various Tn-seq screens of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M and identified a set of genes predicted as important for growth in 2YT nutrient rich media, <italic toggle="yes">in vitro</italic> in the RAW 264.7 macrophage cell line and <italic toggle="yes">in vivo</italic> in lungs from intranasally infected wild-type C57BL/6 mice [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>]. Our main findings were that the genes that are essential for the multiplication of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis in vitro</italic> and <italic toggle="yes">in vivo</italic> are different and vary according to the immune status of the host.</p>
      <p>Numerous observations suggest that the host is not a homogeneous environment for <italic toggle="yes">Brucella</italic>. In our mouse model, the early phase of the protective immune response against <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> varies according to the organs: at 120 hours post-infection, an IL-17RA-dependent (Th17) response controls the infection in the lungs [<xref rid="ppat.1012459.ref017" ref-type="bibr">17</xref>] and an IFN&#x3B3;-dependent (Th1) response controls the infection in the spleen [<xref rid="ppat.1012459.ref018" ref-type="bibr">18</xref>]. <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> persists for more than 50 days in the spleen of infected mice but disappears after a few weeks from the lungs [<xref rid="ppat.1012459.ref019" ref-type="bibr">19</xref>,<xref rid="ppat.1012459.ref020" ref-type="bibr">20</xref>]. In addition, confocal microscopy analysis has demonstrated that <italic toggle="yes">Brucella</italic>-infected cells in the lung [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>,<xref rid="ppat.1012459.ref021" ref-type="bibr">21</xref>] and spleen [<xref rid="ppat.1012459.ref022" ref-type="bibr">22</xref>,<xref rid="ppat.1012459.ref023" ref-type="bibr">23</xref>] display a very different phenotype. Thus, we hypothesize that both the available nutrients as well as the microbicidal mechanisms encountered by <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the lungs and spleen are different and that therefore a different set of bacterial genes might be required for the multiplication of <italic toggle="yes">Brucella</italic> in each organ. To test this hypothesis in this study we used Tn-seq screens to identify genes contributing to the fitness of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M in spleen from wild-type and IFN&#x3B3;-R<sup>-/-</sup> C57BL/6 infected mice. By comparing these genes to those previously found in the lungs [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>], we can select genes specifically necessary for the multiplication of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the spleen and test whether they can help us to develop a safer brucellosis vaccine.</p>
    </sec>
    <sec sec-type="results" id="sec002">
      <title>Results</title>
      <sec id="sec003">
        <title>Tn-Seq identification of bacterial genes affecting the fitness of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the spleen of wild-type mice</title>
        <p>As described previously [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>], a <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M library of 3&#xD7;10<sup>6</sup> random mutants was constructed using a Kan<sup>R</sup> derivative of the mini-Tn<italic toggle="yes">5</italic> transposon. This library was exposed to different selection conditions, such as culture in a 2YT rich medium for 24 hours, and in lungs from intranasally infected C57BL/6 mice for 120 hours. Following selection, surviving bacteria were collected and DNA was extracted and sequenced to identify mini-Tn5 insertion sites. For each selection condition, an average insertion index, called the <bold>transposon insertion frequency</bold> (<bold>TnIF</bold>), was associated with each gene of the <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genome. The TnIF is equal to the log<sub>10</sub> (r+1) for a given coding sequence, with r = number of reads aligned in the central 80% of the coding sequence of the considered gene, as described in Materials and Methods.</p>
        <p>The 2YT condition is the control condition (CTRL) for all our Tn-seq analyses of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M, because whatever the condition analyzed, the bacteria are always cultured in 2YT after mice infection. Genes exhibiting a drop in TnIF of more than 0.5 compared to the average TnIF for the entire genome in the 2YT condition are considered to cause a significant attenuation of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in 2YT. The threshold of 0.5 was determined based on the standard deviation of the bimodal TnIF distribution of the whole genome. It corresponds to 1.6&#x2013;2.6 standard deviations, as described in the Materials and Methods. According to this criterion, 2460 of the 3369 genes of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M are considered not to cause significant growth defect in the 2YT condition. Only these genes are analyzed under the other selection conditions.</p>
        <p><bold>&#x394;TnIF</bold> is calculated to quantify the attenuation of a gene in a condition other than 2YT. &#x394;TnIF = TnIF<sub>cdt</sub>&#x2212;TnIF<sub>CTRL</sub>, where TnIF is computed for the test condition (TnIF<sub>cdt</sub>) and the control condition (TnIF<sub>CTRL</sub>).</p>
        <p>In the present study, wild-type C57BL/6 mice were intraperitoneally infected with 5x10<sup>6</sup> CFU of our <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M transposon mutant library and sacrificed at 120 hours post-infection, what corresponds to the peak of infection in the spleen [<xref rid="ppat.1012459.ref018" ref-type="bibr">18</xref>]. As described previously [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>], this high dose is necessary to administer the entire bank to each mouse and avoid bottleneck effects. Bacteria were extracted from this organ and analyzed as indicated in the Materials and Methods. The intraperitoneal route of infection was used in order to avoid the risk of a bottleneck which would lead to a sampling effect in the library. The TnIF values for each gene in the spleen condition were compared with those obtained previously [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>] in the 2YT and lung conditions (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 1). A &#x394;TnIF for each gene in the lung and spleen conditions was calculated, as indicated previously and summarized in the Material and Methods section.</p>
        <p>A dot plot representation was used to visualize the differences between the lung and spleen conditions, where each dot corresponds to a <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> gene defined by &#x394;TnIF values in the lung and spleen (<xref rid="ppat.1012459.g001" ref-type="fig">Fig 1A</xref>). Among the 2460 genes analyzed (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 2), 257 genes are predicted, if inactivated, to cause a significant drop in <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> fitness in the spleen condition and the same prediction was made for 135 genes in the lung condition (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 3 and 4, respectively). Only 87 genes are common to these two conditions (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 5), which implies that 170 genes are specific to the spleen condition (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 6) and 48 to the lung condition (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 7).</p>
        <fig position="float" id="ppat.1012459.g001">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Comparison of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes required for optimal multiplication in the lung and the spleen conditions in wild-type and IFN&#x3B3;R<sup>-/-</sup> mice.</title>
            <p>The figure shows the distribution of the &#x394;TnIF values of all <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes (n = 2460) predicted not to induce an attenuation of fitness in 2YT rich medium (CTRL). Each gene is defined by two &#x394;TnIF values. (<bold>A</bold>) The x-axis indicates the &#x394;TnIF value for the lung of wt mice (TnIFlung&#x2014;TnIF<sub>CTRL</sub>) and the y-axis indicates the &#x394;TnIF value for the spleen of wt mice (TnIF <sub>spleen wt</sub>&#x2014;TnIF<sub>CTRL</sub>) at 120 hours post-infection. These &#x394;TnIF value comparisons show all the genes associated with a drop in fitness both in the lung and wt spleen (brown area), in the lung specifically (green area) or in the wt spleen specifically (pink area). (<bold>B</bold>) The x-axis indicates the &#x394;TnIF value for the spleen of IFN&#x3B3;R<sup>-/-</sup> mice (TnIF <sub>spleen IFN&#x3B3;R-/-</sub>&#x2014;TnIF<sub>CTRL</sub>) and the y-axis indicates the &#x394;TnIF value for the spleen of wt mice (TnIF <sub>spleen wt</sub>&#x2014;TnIF<sub>CTRL</sub>) at 120 hours post-infection. These &#x394;TnIF value comparisons show all the genes restored in the IFN&#x3B3;R<sup>-/-</sup> spleen (pink area).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g001" position="float"/>
        </fig>
        <p>A clustering analysis with the STRING database was carried out on the genes presenting a strong drop (-1.0) in &#x394;TnIF. The 48 genes displaying a &#x394;TnIF &lt; -1.0 in both the lungs and the spleen included 6 gene clusters (<xref rid="ppat.1012459.g002" ref-type="fig">Fig 2</xref>). These include a cluster of 9 genes involved in purine (<italic toggle="yes">purA</italic>,<italic toggle="yes">B</italic>,<italic toggle="yes">C</italic>,<italic toggle="yes">E</italic>,<italic toggle="yes">H</italic>,<italic toggle="yes">Q</italic>,<italic toggle="yes">S</italic>) and histidine (<italic toggle="yes">hisA</italic>,<italic toggle="yes">H</italic>) synthesis, a cluster of 2 genes associated with methionine transport (<italic toggle="yes">metN</italic>,<italic toggle="yes">I</italic>), a cluster of 2 genes involved in central carbohydrate metabolism (<italic toggle="yes">fba</italic>, <italic toggle="yes">ppdK</italic>), a cluster of 2 genes involved in fatty acid oxidation (<italic toggle="yes">fadA</italic>,<italic toggle="yes">J</italic>), a cluster of 12 genes necessary for the synthesis of the lipopolysaccharide (LPS) (<italic toggle="yes">galU</italic>, <italic toggle="yes">gmd</italic>, <italic toggle="yes">per</italic>, <italic toggle="yes">pgm</italic>, <italic toggle="yes">manB</italic><sub><italic toggle="yes">core</italic></sub><italic toggle="yes">/rfbK</italic>, <italic toggle="yes">wboA</italic>, <italic toggle="yes">wboB</italic>, <italic toggle="yes">wbkD</italic>, <italic toggle="yes">wbpZ/wbkE</italic>, <italic toggle="yes">wbkA</italic>, <italic toggle="yes">wbpL/wbkF</italic>, <italic toggle="yes">wzt</italic>) and a cluster of 12 genes forming the <italic toggle="yes">virB</italic> operon (<italic toggle="yes">vjbR</italic>, <italic toggle="yes">virB1-11</italic>) and encoding the type IV secretion system VirB and its transcriptional regulator VjbR [<xref rid="ppat.1012459.ref024" ref-type="bibr">24</xref>,<xref rid="ppat.1012459.ref025" ref-type="bibr">25</xref>].</p>
        <fig position="float" id="ppat.1012459.g002">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Clustering analysis of very low fitness genes common to the lung and spleen conditions at 120 hours post-infection.</title>
            <p>The diagram shows the potential interactions between the 48 genes displaying a &#x394;TnIF &lt; -1.0 identified in the lungs and spleen of wild-type mice at 120 hours post-infection. The color code represents the different pathways. This clustering analysis was carried out with the STRING database (<ext-link xlink:href="https://string-db.org" ext-link-type="uri">https://string-db.org</ext-link>).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g002" position="float"/>
        </fig>
        <p>Among the 12 genes displaying a &#x394;TnIF &lt; -1.0 in the lungs and &gt; -0.5 in the spleen, a clustering analysis identified a cluster of 6 genes (<italic toggle="yes">trpA</italic>,<italic toggle="yes">B</italic>,<italic toggle="yes">C</italic>,<italic toggle="yes">D</italic>,<italic toggle="yes">E</italic>,<italic toggle="yes">F</italic>) involved in tryptophan synthesis, a cluster of 2 genes (<italic toggle="yes">bveA</italic>, <italic toggle="yes">mprF</italic>) associated with polymyxin resistance and a cluster of 2 genes (<italic toggle="yes">ctaA</italic>,<italic toggle="yes">G</italic>) associated with respiration that are indispensable in the lungs and not in the spleen (<xref rid="ppat.1012459.g003" ref-type="fig">Fig 3A</xref>).</p>
        <fig position="float" id="ppat.1012459.g003">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title>Clustering analysis of very low fitness genes specifically in the lung or spleen condition in wild-type mice at 120 hours post-infection.</title>
            <p>The diagram shows the potential interactions between genes displaying a &#x394;TnIF &lt; -1.0 identified in the lungs or spleen of wild-type mice at 120 hours post-infection (12 genes in the lungs (<bold>A</bold>) and 34 genes in the spleen (<bold>B</bold>)). The color code represents the different pathways. This clustering analysis was carried out with the STRING database (<ext-link xlink:href="https://string-db.org" ext-link-type="uri">https://string-db.org</ext-link>).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g003" position="float"/>
        </fig>
        <p>Regarding the genes displaying a &#x394;TnIF &lt; -1.0 in the spleen and &gt; -0.5 in the lungs, we identified 4 small clusters (<xref rid="ppat.1012459.g003" ref-type="fig">Fig 3B</xref>). A cluster of 3 genes (<italic toggle="yes">tac4</italic>, <italic toggle="yes">gltB</italic>, <italic toggle="yes">hisE</italic>) associated with amino acid biosynthesis, a cluster of 3 genes (<italic toggle="yes">znuA</italic>,<italic toggle="yes">B</italic>,<italic toggle="yes">C</italic>) encoding a zinc transporter, a cluster of 3 genes (<italic toggle="yes">czcA</italic>, <italic toggle="yes">triA</italic>, BMEI0381) identified as an efflux transporter and a cluster of 2 genes (BMEI1934, BMEI1935) identified as an ABC transporter. Other 23 genes could not be linked to a gene cluster and 5 of them were unidentified before this study.</p>
        <p>To summarize our Tn-seq data, we produced schematic representations of the LPS synthesis pathway (<xref rid="ppat.1012459.g004" ref-type="fig">Fig 4</xref>) and of the central carbohydrate metabolism (<xref rid="ppat.1012459.g005" ref-type="fig">Fig 5</xref>) and attempted to give a general view of the metabolism of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> by connecting these pathways to the tricarboxylic acid cycle, glutamine metabolism as well as the histidine and adenine/adenosine synthesis pathways (<xref rid="ppat.1012459.g006" ref-type="fig">Fig 6</xref>). Interpretations are proposed in the Discussion section.</p>
        <fig position="float" id="ppat.1012459.g004">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g004</object-id>
          <label>Fig 4</label>
          <caption>
            <title>Identification of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes implicated in the lipopolysaccharide biosynthesis pathway required for optimal multiplication in the lungs and spleen of wild-type mice.</title>
            <p>Schematic representation of the lipopolysaccharide biosynthesis pathway of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> with genes attenuated in 2YT rich medium highlighted in red and genes required in the lung and spleen highlighted in blue (adapted from the KEGG PATHWAY database, <ext-link xlink:href="https://www.genome.jp/kegg/pathway.html" ext-link-type="uri">https://www.genome.jp/kegg/pathway.html</ext-link>).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g004" position="float"/>
        </fig>
        <fig position="float" id="ppat.1012459.g005">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g005</object-id>
          <label>Fig 5</label>
          <caption>
            <title>Identification of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes required in the central carbohydrate metabolism network for optimal multiplication in the lungs and spleen of wild-type mice.</title>
            <p>Schematic representation of the glycolysis, pentose phosphate and Entner-Doudoroff pathways in <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> with genes attenuated in 2YT rich medium highlighted in red and genes attenuated in the lung and spleen, required only in the lung or only in the spleen respectively in blue, pink and green (adapted from the KEGG PATHWAY database, <ext-link xlink:href="https://www.genome.jp/kegg/pathway.html" ext-link-type="uri">https://www.genome.jp/kegg/pathway.html</ext-link>).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g005" position="float"/>
        </fig>
        <fig position="float" id="ppat.1012459.g006">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g006</object-id>
          <label>Fig 6</label>
          <caption>
            <title>Integrated view of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes required in different metabolic pathways for optimal multiplication in lungs and spleen of wild-type mice.</title>
            <p>Schematic representation of lipopolysaccharide (LPS) synthesis, the pentose phosphate (PP) pathway, the fatty acid &#x3B2; oxidation, glucose (G) pathway and the tricarboxylic acid (TCA) cycle in <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> with genes attenuated in 2YT rich medium highlighted in red and genes attenuated in the lung and spleen, required only in the lung or only in the spleen respectively in blue, pink and green (adapted from the KEGG PATHWAY database, <ext-link xlink:href="https://www.genome.jp/kegg/pathway.html" ext-link-type="uri">https://www.genome.jp/kegg/pathway.html</ext-link>).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g006" position="float"/>
        </fig>
        <p>We attempted to confirm certain predictions from our Tn-seq analyses by producing deletion mutants of a few genes of interest. We selected <italic toggle="yes">trpD</italic> (BMEI0843), predicted to cause attenuation in the lungs; <italic toggle="yes">znuA</italic> (BMEII0178) and <italic toggle="yes">lysR</italic> (BMEI0513), predicted to cause attenuation in the spleen; and <italic toggle="yes">gmd</italic> (BMEI1426), <italic toggle="yes">purH</italic> (BMEI0233) as well as the <italic toggle="yes">virB</italic> operon genes, predicted to cause attenuation in both the lungs and the spleen. The wild-type (<italic toggle="yes">wt</italic>), &#x394;<italic toggle="yes">gmd</italic>, &#x394;<italic toggle="yes">lysR</italic>, &#x394;<italic toggle="yes">purH</italic>, &#x394;<italic toggle="yes">trpD</italic>, &#x394;<italic toggle="yes">virB</italic> and &#x394;<italic toggle="yes">znuA</italic> strains were intranasally administered at a dose of 5x10<sup>6</sup> CFU to wild-type C57BL/6 mice and the number of bacteria present in the lungs at 120 hours post infection was measured by CFU counting (<xref rid="ppat.1012459.g007" ref-type="fig">Fig 7A</xref>). The same strains were administered at the same dose by the intraperitoneal route to wild-type C57BL/6 mice and the number of CFUs in the spleen at 120 hours was determined (<xref rid="ppat.1012459.g007" ref-type="fig">Fig 7B</xref>). The Tn-seq predictions for each of these genes in the lungs and spleen are shown in <xref rid="ppat.1012459.g007" ref-type="fig">Fig 7C and 7D</xref>, respectively. We observed that the level of persistence of deletion mutants in the lungs and spleen was qualitatively well predicted by our Tn-Seq data. The &#x394;<italic toggle="yes">gmd</italic>, &#x394;<italic toggle="yes">purH</italic> and &#x394;<italic toggle="yes">virB</italic> strains were significantly attenuated compared to the wild-type strain in the lungs and spleen while the &#x394;<italic toggle="yes">trpD</italic> strain was attenuated only in the lungs and the &#x394;<italic toggle="yes">lysR</italic> and &#x394;<italic toggle="yes">znuA</italic> strains were only attenuated in the spleen. Overall, our data demonstrate that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M is subject to different selection pressures in the lungs and spleen of C57BL/6 mice.</p>
        <fig position="float" id="ppat.1012459.g007">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g007</object-id>
          <label>Fig 7</label>
          <caption>
            <title>Functional confirmation of the prediction derived from the Tn-seq analysis of lung and spleen conditions in wild-type mice.</title>
            <p>Data shown in panels (<bold>A</bold>) and (<bold>B</bold>) are bacterial counts (CFU) at 120 hours post-infection in (<bold>A</bold>) lungs from wild-type mice infected intranasally and (<bold>B</bold>) the spleen from wild-type mice infected intraperitoneally with wild-type (wt), &#x394;<italic toggle="yes">trpD</italic>, &#x394;<italic toggle="yes">lysR</italic>, &#x394;<italic toggle="yes">znuA</italic>, &#x394;<italic toggle="yes">virB</italic>, &#x394;<italic toggle="yes">gmd</italic> and &#x394;<italic toggle="yes">purH</italic> strains of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> at the dose of 5x10<sup>6</sup> CFU. Red lines represent the geometric mean. Dotted lines represent the mean of the wild-type condition. Significant differences between wt and the indicated groups are marked with asterisks: *p &lt; 0.1, ***p &lt; 0.001, in a (Wilcoxon-)Mann-Whitney post-test. These results are representative of three independent experiments. Data shown in panels (<bold>C</bold>) and (<bold>D</bold>) are the prediction derived from the Tn-Seq analysis expressed in &#x394;TnIF. &#x394;TnIF of genes in lungs from wild-type mice infected intranasally (TnIF lung&#x2014;TnIF<sub>CTRL</sub>) are represented in (<bold>C</bold>). &#x394;TnIF of genes in the spleen from wild-type mice infected intraperitoneally (TnIF spleen&#x2014;TnIF<sub>CTRL</sub>) are represented in (<bold>D</bold>). The color code of the legend indicates whether the genes are specifically attenuated in the lung (green), in the spleen (orange) or in both (blue) at 120 hours post-infection.</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g007" position="float"/>
        </fig>
      </sec>
      <sec id="sec004">
        <title>Absence of the IFN-&#x3B3;R dependent signaling pathway affects the nature of essential bacterial genes in the spleen</title>
        <p>Interferon-&#x3B3; (IFN-&#x3B3;) is well known to control <italic toggle="yes">Brucella</italic> growth <italic toggle="yes">in vivo</italic> as well as <italic toggle="yes">Brucella</italic>-induced inflammation [<xref rid="ppat.1012459.ref026" ref-type="bibr">26</xref>]. Using the mouse model of intraperitoneal infection by <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic>, we have previously shown that production of IFN-&#x3B3; in the spleen presents a peak at 120 hours post-infection and is mainly due to CD4<sup>+</sup> T cells [<xref rid="ppat.1012459.ref027" ref-type="bibr">27</xref>]. In principle, comparison of the genes that are essential for the growth of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the spleen of wild-type and IFN-&#x3B3;R<sup>-/-</sup> mice should identify genes required for resistance to the IFN-&#x3B3;-dependent immune response.</p>
        <p>We infected IFN-&#x3B3;R<sup>-/-</sup> C57BL/6 mice with 5x10<sup>6</sup> CFU from our <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> mini-Tn5 library. Mice were sacrificed at 120 hours post-infection, the spleen was collected, and bacteria were isolated and analyzed as described above. We point out that although the IFN-&#x3B3; pathway is essential for the control of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> infection in the spleen [<xref rid="ppat.1012459.ref018" ref-type="bibr">18</xref>], infected IFN-&#x3B3;R<sup><italic toggle="yes">-/-</italic></sup> C57BL/6 mice do not yet show any clinical signs at this time of infection. We then compared the &#x394;TnIF for the wild-type and IFN-&#x3B3;R<sup>-/-</sup> spleen conditions (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 2) for the 2460 genes which are not predicted to cause growth failure for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the 2YT condition using a dot plot presentation where each dot represents a gene (<xref rid="ppat.1012459.g001" ref-type="fig">Fig 1B</xref>). Our results showed that among the 257 genes displaying a &#x394;TnIF &lt; -0.5 in the wild-type spleen condition, only 102 displayed a &#x394;TnIF &lt; -0.5 in the IFN-&#x3B3;R<sup>-/-</sup> spleen condition. Thus, 155 <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes predicted to cause attenuation in spleen are not predicted to cause attenuation in the spleen of IFN&#x3B3;R<sup>-/-</sup> mice. Therefore, numerous genes seem to be involved in resistance to the IFN-&#x3B3;-dependent immune response. <xref rid="ppat.1012459.s005" ref-type="supplementary-material">S2 Table</xref> presents a list of the 19 genes presenting a &#x394;TnIF &lt; -1.0 (very low fitness) in the wild-type spleen condition and a &#x394;TnIF &gt; -0.5 (predicted not attenuated) in the IFN&#x3B3;R<sup>-/-</sup> spleen condition. Unfortunately, a clustering analysis of these genes using the STRING database did not allow us to identify any cluster of genes, making it impossible to propose a hypothesis explaining how these genes are involved in the resistance of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> to the Th1 immune response.</p>
        <p>In order to validate our Tn-seq predictions in the IFN&#x3B3;R<sup>-/-</sup> spleen condition, we compared the persistence in the spleen of wild-type and IFN-&#x3B3;R<sup><italic toggle="yes">-/-</italic></sup> mice of a deletion mutant of the <italic toggle="yes">lysR</italic> gene (BMEI0513, also called lysR21 and <italic toggle="yes">vtlR</italic> [<xref rid="ppat.1012459.ref028" ref-type="bibr">28</xref>]). This gene displayed a &#x394;TnIF in the wild-type condition of -0.73 and a &#x394;TnIF of +0.56 in the IFN&#x3B3;R<sup>-/-</sup> spleen condition. We infected wild-type and IFN-&#x3B3;R<sup>-/-</sup> mice with 5x10<sup>6</sup> CFU of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M or the &#x394;<italic toggle="yes">lysR</italic> mutant. Evaluation of the number of bacteria at 120 hours post-infection confirmed the one log-attenuation of the &#x394;<italic toggle="yes">lysR</italic> strain in the spleen of wild-type mice while the mutant showed no attenuation in the spleen of IFN-&#x3B3;R<sup>-/-</sup> mice (<xref rid="ppat.1012459.g008" ref-type="fig">Fig 8</xref>). These results fully validate our Tn-seq predictions regarding the <italic toggle="yes">lysR</italic> gene.</p>
        <fig position="float" id="ppat.1012459.g008">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g008</object-id>
          <label>Fig 8</label>
          <caption>
            <title>Functional confirmation of the prediction derived from the Tn-seq analysis of the spleen condition in wild-type and IFN-&#x3B3;R<sup><italic toggle="yes">-/-</italic></sup> mice.</title>
            <p>Data shown are bacterial count s(CFU) at 120 hours post-infection in the spleen from wild-type and IFN-&#x3B3;R<sup>-/-</sup> mice infected intraperitoneally with wild-type (wt) or &#x394;<italic toggle="yes">lysR</italic> strains of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> at a dose of 5x10<sup>6</sup> CFU. Red lines represent the geometric mean. Dotted lines represent the mean of the wild-type condition. Significant differences between wt and the indicated groups are marked with asterisks: ***p &lt; 0.001, in a (Wilcoxon-)Mann-Whitney post-test. These results are representative of two independent experiments.</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g008" position="float"/>
        </fig>
      </sec>
      <sec id="sec005">
        <title>Selection of new vaccine candidates based on lung and spleen Tn-seq results</title>
        <p>Ideally, to be protective, a brucellosis vaccine should multiply long enough in the lungs and spleen to induce mucosal and systemic immunity. Furthermore, an ideal vaccine should also not be able to persist in the spleen, which is the main known reservoir of <italic toggle="yes">Brucella</italic> in mice. To select genes whose deletion could lead to this type of behavior for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic>, we should have Tn-seq data at different points of infection, for example at 5, 12 and days post infection. Unfortunately, in our model of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> infection, we only have Tn-seq data in the spleen up to 5 days post-infection. Beyond that period, the drop in the CFU count could lead to a bottleneck effect which causes sampling effects and makes the Tn-seq data uninterpretable. Therefore, we were not able to identify the <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes necessary for a long-term chronic infection of the spleen. Accordingly, we decided to select genes whose inactivation is not expected to cause strong attenuation in the lungs, and which are expected to cause moderate or strong attenuation in the spleen at 120 hours post-infection. We hypothesized that genes thought to induce moderate attenuation at 120 hours in the spleen will cause stronger attenuation in the chronic phases of infection.</p>
        <p>Bearing the above in mind, from the 3369 genes of the <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genome we selected the 2460 genes that, when inactivated, were not predicted to cause an attenuation in 2YT medium (TnIF &gt; 2.7 in 2YT condition) (<xref rid="ppat.1012459.g009" ref-type="fig">Fig 9</xref>). Then, we selected the 2387 genes predicted not to cause strong attenuation in the lungs when inactivated (&#x394;TnIF &gt; -1.0 in the lung condition). From this category we selected the genes whose deletion was predicted to cause a moderate (&#x394;TnIF between -1.0 and -2.0 in wild-type spleen condition) or a strong attenuation (&#x394;TnIF between &lt; -2.0 in wild-type spleen condition) in the spleen (<xref rid="ppat.1012459.g009" ref-type="fig">Fig 9</xref>). Finally, we verified that these candidates remain predicted as attenuated in IFN&#x3B3;R<sup>-/-</sup> mice (&#x394;TnIF &lt; -0.5 in the IFN&#x3B3;R<sup>-/-</sup> spleen condition) to avoid a possible increase in virulence of the vaccine strain in the event of a deficient Th1 response. From the 3 genes predicted to cause strong attenuation in the spleen (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 7) we selected <italic toggle="yes">murI</italic> (BMEI0795) and from the 17 genes predicted to cause moderate attenuation (<xref rid="ppat.1012459.s004" ref-type="supplementary-material">S1 Table</xref>, page 8) we selected <italic toggle="yes">plsC</italic> (BMEI1977). We selected these two genes because although the enzymatic functions of the encoding proteins are known, their role in <italic toggle="yes">Brucella</italic> pathogenesis has, to our knowledge, not yet been investigated.</p>
        <fig position="float" id="ppat.1012459.g009">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g009</object-id>
          <label>Fig 9</label>
          <caption>
            <title>Tn-seq based strategy for selection of genes for development of vaccine candidates.</title>
            <p>We selected genes whose deletion could optimize a strain of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> to safely induce protective immunity. In practice, we selected the genes able to produce deletion mutants that induce a systemic immune response but do not persist long term in the spleen reservoir. Only genes that are not required to grow on 2YT rich medium were kept (&#x394;TnIF &gt; 2.7) (2460 genes). In this group, genes that are not strongly attenuated (&#x394;TnIF &gt; -1.0) in the lungs were conserved (2387 genes). Two different thresholds were then applied for the spleen condition in wild-type (wt) mice: either strongly attenuated (&#x394;TnIF &lt; -2.0) or moderately attenuated (-2.0&lt;&#x394;TnIF&lt;-1.0). In addition, the candidate must not revert in immune deficient mice (IFN&#x3B3;R<sup>-/-</sup>) (&#x394;TnIF &lt; -0.5). &#x394;TnIF corresponds to the TnIF tested condition&#x2014;TnIF<sub>CTRL</sub> (2YT rich medium).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g009" position="float"/>
        </fig>
        <p>Tn-seq predictions for these two genes were verified by constructing deletion mutants and measuring their persistence in the spleen (<xref rid="ppat.1012459.g010" ref-type="fig">Fig 10</xref>). For that purpose, wild-type C57BL/6 mice were infected intranasally or intraperitoneally with 5&#xD7;10<sup>6</sup> CFU of the wt, &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> strains and sacrificed at 120 hours post-infection, and the numbers of bacteria was evaluated in the lungs and spleen by CFU-counting. Our observations confirmed that inactivation of both genes leads to low attenuation in the lungs (-1.0 and -0.5 log CFU, respectively) and that inactivation of <italic toggle="yes">murI</italic> and <italic toggle="yes">plsC</italic> induces strong (-2.0 log CFU) and moderate (-1.3 log CFU) attenuation in spleen, respectively.</p>
        <fig position="float" id="ppat.1012459.g010">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g010</object-id>
          <label>Fig 10</label>
          <caption>
            <title>Functional confirmation of the prediction derived from Tn-seq analysis of the lung and spleen conditions in wild-type mice for the <italic toggle="yes">murI</italic> and <italic toggle="yes">plsC</italic> genes.</title>
            <p>Data shown in panels (<bold>A</bold>) and (<bold>B</bold>) are bacterial counts (CFU) at 120 hours post-infection in (<bold>A</bold>) lungs from wild-type mice infected intranasally and (<bold>B</bold>) the spleen from wild-type mice infected intraperitoneally with wild-type (wt), &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> strains of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> at a dose of 5x10<sup>6</sup> CFU. Red lines represent the geometric mean. Dotted lines represent the mean of the wild-type condition. Significant differences between wt and the indicated groups are marked with asterisks: *p &lt; 0.1, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, in a (Wilcoxon-)Mann-Whitney post-test. These results are representative of three independent experiments. Data shown in panels (<bold>C</bold>) and (<bold>D</bold>) are the prediction derived from the Tn-Seq analysis expressed in &#x394;TnIF of genes in the lungs (<bold>C</bold>) and spleen (<bold>D</bold>) from wild-type mice infected intraperitoneally (TnIF spleen&#x2014;TnIF<sub>CTRL</sub>).</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g010" position="float"/>
        </fig>
        <p>To ensure that the observed phenotype was indeed consequence of the absence of the <italic toggle="yes">murI</italic> and <italic toggle="yes">plsC</italic> genes and not a non-specific effect caused by the deletion, we complemented these mutants with an intact coding sequence on a low copy plasmid, as indicated in the Material and Methods section. We observed that the complemented strains displayed a level of CFU in the lungs and spleen close to that of the wt strain (<xref rid="ppat.1012459.s001" ref-type="supplementary-material">S1 Fig</xref>), demonstrating that the attenuation of the mutants was not due to off-target effects.</p>
        <p>Finally, as we planned to test the protective capacity of these vaccine candidates in the intranasal vaccination model with a dose of 10<sup>5</sup> CFU characterized previously [<xref rid="ppat.1012459.ref017" ref-type="bibr">17</xref>,<xref rid="ppat.1012459.ref020" ref-type="bibr">20</xref>], we also tested the persistence of the &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> strains in the lungs and the spleen under these conditions. Wild-type C57BL/6 mice were infected intranasally with 10<sup>5</sup> CFU of the wt, &#x394;<italic toggle="yes">virB</italic>, &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> strains as well as with the Rev.1 vaccine. The &#x394;<italic toggle="yes">vir</italic>B strain was used as a negative control due to its low persistence in the lungs and spleen. Comparison of our mutant strains with the Rev.1 vaccine will allow us to determine whether our vaccines persist less in animals than the reference vaccine and therefore whether we can expect these vaccine candidates to be safer than Rev.1. As expected, we observed (<xref rid="ppat.1012459.g011" ref-type="fig">Fig 11</xref>) that the &#x394;<italic toggle="yes">virB</italic> strain was rapidly eliminated from the lungs and did not colonize the spleen. The &#x394;<italic toggle="yes">murI</italic> strain persisted for up to 12 days in the lungs but was unable to colonize the spleen. In contrast, the &#x394;<italic toggle="yes">plsC</italic> strain persisted in the lungs at the same level as the &#x394;<italic toggle="yes">murI</italic> strain but succeeded in colonizing the spleen. At 12 days, the level of bacteria in the spleen from the &#x394;<italic toggle="yes">plsC</italic> strain and Rev.1 were close to that associated with the wt strain. However, &#x394;<italic toggle="yes">plsC</italic> bacterial burden dropped drastically at 28 days post-infection while the wt strain and Rev.1 persisted in the spleen. Under our vaccination conditions, the &#x394;<italic toggle="yes">murI</italic> strain is therefore able to multiply in the lungs but is not able to colonize the spleen, whereas the &#x394;<italic toggle="yes">plsC</italic> strain can temporarily colonize the spleen but is unable to establish itself there over the long term.</p>
        <fig position="float" id="ppat.1012459.g011">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g011</object-id>
          <label>Fig 11</label>
          <caption>
            <title>Comparison of long-term persistence of different vaccine candidates in the lungs and spleen.</title>
            <p>Wild-type C57BL/6 mice were infected intranasally with 10<sup>5</sup> CFU of different <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> strains: wild-type, &#x394;<italic toggle="yes">murI</italic>, &#x394;<italic toggle="yes">plsC</italic>, Rev.1 or &#x394;<italic toggle="yes">virB</italic>. This dose was used to mimic the infection following vaccination. Data shown are bacterial counts (CFU) at 5 (<bold>A</bold>), 12 (<bold>B</bold>) and 28 (<bold>C</bold>) days post-infection in the lung and at 5 (<bold>D</bold>), 12 (<bold>E</bold>) and 28 (<bold>F</bold>) days post-infection in the spleen. Red lines represent the geometric mean. Dotted red lines represents the mean of the wild-type strain. Significant differences between wt and the indicated groups are marked with asterisks: *p &lt; 0.1, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, in a (Wilcoxon-)Mann-Whitney post-test. These results are representative of three independent experiments.</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g011" position="float"/>
        </fig>
      </sec>
      <sec id="sec006">
        <title>Evaluation of the protective capacity of the &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> vaccine candidates</title>
        <p>In order to assess the ability of the &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> vaccine candidates to induce a long-lasting protective memory, wild-type C57BL/6 mice intranasally received 10<sup>5</sup> CFU of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> wt, Rev.1, &#x394;<italic toggle="yes">virB</italic>, &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> strains and were challenged 6 weeks later via the same route with 10<sup>5</sup> CFU of the virulent <italic toggle="yes">wt</italic> strain, as described in the Materials and Methods. This challenge strain expressed a fluorochrome and resistance to kanamycin in order to be differentiated from the vaccination strains. One group of mice (control) was not vaccinated. As expected, we observed that the wt and Rev.1 strains induced a very effective immune response that reduced the challenge strain load in the lungs and spleen by 3 log CFU (<xref rid="ppat.1012459.g012" ref-type="fig">Fig 12</xref>). In contrast, the &#x394;<italic toggle="yes">virB</italic> strain induced no or very weak detectable protective immunity in the lungs and spleen (-0.5 log CFU), respectively. Finally, &#x394;<italic toggle="yes">murI</italic> induced only weak immunity in the lungs and spleen (-1 log CFU) whereas &#x394;<italic toggle="yes">plsC</italic> induced a protective immune response similar to the wild-type and Rev.1 strains.</p>
        <fig position="float" id="ppat.1012459.g012">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1012459.g012</object-id>
          <label>Fig 12</label>
          <caption>
            <title>Evaluation of the protective capacity of &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> vaccine candidates.</title>
            <p>Wild-type C57BL/6 mice were immunized intranasally with 10<sup>5</sup> CFU of different <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> strains: wild-type, Rev.1, &#x394;<italic toggle="yes">virB</italic>, &#x394;<italic toggle="yes">murI</italic> or &#x394;<italic toggle="yes">plsC</italic>. Wild-type <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M strain and the Rev.1 vaccine were used as positive controls. &#x394;<italic toggle="yes">virB</italic> was used as the negative control, as it is known to be rapidly eliminated from the body and thus does not have time to induce a memory response. &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> were the selected vaccine candidates. Unvaccinated (control) and vaccinated wild-type mice were challenged intranasally at 6 weeks post-vaccination with 10<sup><italic toggle="yes">5</italic></sup> CFU of wild-type mCherry&#x2013;<italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> and sacrificed at 12 days post-infection. The data represent the number of CFU/g in the lung (<bold>A</bold>) and spleen (<bold>B</bold>). Red lines represent the geometric mean. Dotted lines represent the mean of CFU for unvaccinated mice. Significant differences between the control (unvaccinated) and groups of vaccinated mice are marked with asterisks: ***p &lt; 0.001, ****p &lt; 0.0001, in a (Wilcoxon-)Mann-Whitney post-test. These results are representative of three independent experiments.</p>
          </caption>
          <graphic xlink:href="ppat.1012459.g012" position="float"/>
        </fig>
        <p>Interestingly, these results could be correlated with the induction of specific <italic toggle="yes">Brucella</italic> IgG2a antibodies since protective strains (<italic toggle="yes">wt</italic>, Rev.1 and &#x394;<italic toggle="yes">plsC</italic>) induced high levels of antibodies while non-protective strains (&#x394;<italic toggle="yes">virB</italic>, &#x394;<italic toggle="yes">murI</italic>) did not (<xref rid="ppat.1012459.s002" ref-type="supplementary-material">S2 Fig</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec007">
      <title>Discussion</title>
      <p>Brucellosis is one of the most common bacterial zoonoses and has a significant economic and public health impact worldwide. <italic toggle="yes">Brucella</italic> infections cause abortions and sterility in ruminants and pigs and a severely debilitating febrile illness in humans [<xref rid="ppat.1012459.ref003" ref-type="bibr">3</xref>&#x2013;<xref rid="ppat.1012459.ref005" ref-type="bibr">5</xref>], an accidental host that become infected through contact with infected animals or by consuming contaminated animal products. Since cases of human-to-human transmission are extremely rare, efforts to control brucellosis should first focus on farm animals. Control of brucellosis in northern European countries and the USA was possible through a policy combining mass vaccination and slaughter of infected herds, a strategy that is difficult to apply in many southern countries, like African countries, where the state cannot compensate breeders for the slaughter of herds or carry out sufficiently rigorous screening for infected animals. In these countries, the fight against brucellosis relies heavily on vaccines. Unfortunately, the only vaccines that are effective on the ground are live attenuated vaccines and those currently recommended, such as S19, RB51 and Rev.1, have several important shortcomings [<xref rid="ppat.1012459.ref009" ref-type="bibr">9</xref>&#x2013;<xref rid="ppat.1012459.ref011" ref-type="bibr">11</xref>].</p>
      <p><italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic>, which mainly infects goats and sheep, is the most pathogenic <italic toggle="yes">Brucella</italic> species for humans [<xref rid="ppat.1012459.ref007" ref-type="bibr">7</xref>]. The live attenuated <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> Rev.1 strain is recommended by the World Organization for Animal Health (WOAH) for vaccination of small ruminants since conjunctival Rev.1 administration successfully protects these animals [<xref rid="ppat.1012459.ref029" ref-type="bibr">29</xref>]. However, this vaccine has several important drawbacks [<xref rid="ppat.1012459.ref009" ref-type="bibr">9</xref>,<xref rid="ppat.1012459.ref030" ref-type="bibr">30</xref>]. Rev.1 is a natural revertant of a virulent <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 6056 strain rendered dependent on streptomycin in the mid-1950s, one of the antibiotics recommended for the treatment of human brucellosis. Also, Rev.1 is a smooth strain and as such induces positive serology which interferes with the diagnosis of brucellosis, it causes dose dependent abortions in small ruminants [<xref rid="ppat.1012459.ref009" ref-type="bibr">9</xref>,<xref rid="ppat.1012459.ref031" ref-type="bibr">31</xref>], it can persist for a long time in the vaccinated animal and be excreted in the milk [<xref rid="ppat.1012459.ref032" ref-type="bibr">32</xref>,<xref rid="ppat.1012459.ref033" ref-type="bibr">33</xref>] and it is virulent for humans [<xref rid="ppat.1012459.ref034" ref-type="bibr">34</xref>,<xref rid="ppat.1012459.ref035" ref-type="bibr">35</xref>]. Comparative proteomic analysis of the virulent <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M strain with the attenuated Rev.1 strain in an acid medium <italic toggle="yes">in vitro</italic> showed that the two strains presented important differences [<xref rid="ppat.1012459.ref036" ref-type="bibr">36</xref>]. At least 403 genes involved in complex cellular processes, like metabolism and transport, are expressed at different levels making very complicated to identify the mechanisms of the attenuation of Rev.1.</p>
      <p>In this study, we tested the rational development of new attenuated vaccine candidates from the virulent <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M strain based on a functional map of its genome produced by Tn-Seq. We have identified the genes that are essential for the multiplication of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M in the spleen from wild-type and IFN&#x3B3;R<sup>-/-</sup> C57BL/6 mice and compared them with the genes previously identified by our team as essential for multiplication in the lungs of C57BL/6 mice [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>]. This comparison enabled us to identify the genes essential for the multiplication of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in both the lungs and spleen as well as the genes specifically necessary for multiplication in the lungs or spleen. The predictions from our Tn-Seq analyses were validated by constructing deletion mutants for the genes of interest and measuring their persistence in the lungs and spleen of infected mice.</p>
      <p>We collected a very large amount of information that will be of interest for future aspects of research on <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic>. Here, we attempt to summarize the major trends in <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> metabolism in mice suggested by the analysis of our Tn-Seq data.</p>
      <p>A clustering analysis of the 48 genes predicted to be essential in both the lungs and spleen identified 6 clusters involved in purine and histidine biosynthesis, methionine transport, carbohydrate metabolism, fatty acid oxidation, LPS biosynthesis and the type IV secretion system encoded by the <italic toggle="yes">virB</italic> operon (<xref rid="ppat.1012459.g002" ref-type="fig">Fig 2</xref>). These data confirm the importance of bacterial genes implicated in LPS synthesis for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> survival <italic toggle="yes">in vivo</italic> [<xref rid="ppat.1012459.ref037" ref-type="bibr">37</xref>]. While most of the genes involved in the biosynthesis of the LPS from glucose and fructose are not essential for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M to multiply in rich medium or in the macrophage line RAW 264.7 [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>], they become essential in the lungs [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>] and spleen (<xref rid="ppat.1012459.g004" ref-type="fig">Fig 4</xref>). This is consistent with the fact that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> is extracellular in the early times of intranasal [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>] and intraperitoneal infection [<xref rid="ppat.1012459.ref038" ref-type="bibr">38</xref>] and therefore exposed to attack by the innate immune system. It is well demonstrated <italic toggle="yes">in vitro</italic> that rough strains (LPS O-chain deficient) of <italic toggle="yes">Brucella</italic> are more sensitive to complement [<xref rid="ppat.1012459.ref039" ref-type="bibr">39</xref>,<xref rid="ppat.1012459.ref040" ref-type="bibr">40</xref>] and bactericidal cationic peptides [<xref rid="ppat.1012459.ref041" ref-type="bibr">41</xref>]. Our data also confirm previous works documenting the importance of genes implicated in methionine transport [<xref rid="ppat.1012459.ref042" ref-type="bibr">42</xref>], purine metabolism [<xref rid="ppat.1012459.ref043" ref-type="bibr">43</xref>] and genes of the <italic toggle="yes">virB</italic> operon [<xref rid="ppat.1012459.ref044" ref-type="bibr">44</xref>], with the exception of <italic toggle="yes">virB12</italic> [<xref rid="ppat.1012459.ref045" ref-type="bibr">45</xref>] for <italic toggle="yes">B</italic>. <italic toggle="yes">abortus</italic> growth in mice.</p>
      <p>Regarding central carbohydrate metabolism, bacteria might present these interconnected pathways: classical glycolysis/gluconeogenesis, the pentose phosphate (PP) pathway, the Entner&#x2013;Doudoroff (ED) pathway and the citric acid cycle (TCA). Numerous <italic toggle="yes">in vitro</italic> studies (reviewed in [<xref rid="ppat.1012459.ref046" ref-type="bibr">46</xref>,<xref rid="ppat.1012459.ref047" ref-type="bibr">47</xref>]) have shown that <italic toggle="yes">Brucella</italic> present a complete TCA cycle but are naturally deficient in the enzyme <italic toggle="yes">pfk</italic> and in consequence, in glycolysis. Therefore, the attenuation generated by <italic toggle="yes">fba</italic> (BMEII0423) deletion suggests an important role for gluconeogenesis during <italic toggle="yes">Brucella</italic> multiplication in lungs and spleen (<xref rid="ppat.1012459.g005" ref-type="fig">Fig 5</xref>), results in accordance with the observations made by other authors [<xref rid="ppat.1012459.ref048" ref-type="bibr">48</xref>,<xref rid="ppat.1012459.ref049" ref-type="bibr">49</xref>] In this regard, inactivation of the <italic toggle="yes">pyk</italic> gene (BMEI0292), which converts phosphoenolpyruvate (PEP) to pyruvate, does not lead to <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> attenuation in any of the conditions tested, while the enzyme PpdK (BMEI1436), which converts pyruvate to PEP, is essential <italic toggle="yes">in vivo</italic> (<xref rid="ppat.1012459.g006" ref-type="fig">Fig 6</xref>). In addition to a possible role of PpdK in gluconeogenesis, the produced PEP is necessary to synthesize phenylalanine, tyrosine, tryptophan, glycerolipids, and other PEP-derived molecules [<xref rid="ppat.1012459.ref049" ref-type="bibr">49</xref>].</p>
      <p>Concerning the ED pathway, the first enzyme of the route, Edd (BMEII0511), is inactive in <italic toggle="yes">B</italic>. <italic toggle="yes">abortus</italic> and <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> due to a nonsynonymous mutation [<xref rid="ppat.1012459.ref047" ref-type="bibr">47</xref>], and therefore, these two strains exclusively use the PP pathway for hexose catabolism. In keeping with this observation, we found that two key enzymes of the PP pathway become indispensable for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M multiplication in the lungs and spleen: <italic toggle="yes">pgl</italic> (BMEII0512) and <italic toggle="yes">rpiA</italic> (BMEI0974) (<xref rid="ppat.1012459.g005" ref-type="fig">Fig 5</xref>). We also observed that many enzymes involved in the synthesis of histidine (<italic toggle="yes">hisA</italic>,<italic toggle="yes">H</italic>) and adenine (<italic toggle="yes">purA</italic>,<italic toggle="yes">B</italic>,<italic toggle="yes">C</italic>,<italic toggle="yes">E</italic>,<italic toggle="yes">H</italic>,<italic toggle="yes">S</italic>,<italic toggle="yes">S</italic>) from 5-phosphoribosyl 1-pyrophosphate produced by the PP pathway become indispensable <italic toggle="yes">in vivo</italic> (<xref rid="ppat.1012459.g006" ref-type="fig">Fig 6</xref>).</p>
      <p>The Tn-seq data suggest that fatty acid catabolism might be important during infection of the lungs and spleen since <italic toggle="yes">fadA</italic> (BMEII0496) and <italic toggle="yes">fadJ</italic> (BMEII0497), putatively required for fatty acid utilization, play an essential role during the multiplication of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M in these organs (<xref rid="ppat.1012459.g006" ref-type="fig">Fig 6</xref>). In this regard, the glyoxylate shunt is essential for utilizing acetate and fatty acids as carbon sources under physiological conditions requiring gluconeogenesis [<xref rid="ppat.1012459.ref050" ref-type="bibr">50</xref>] However, the two enzymes of this cycle, isocitrate lyase <italic toggle="yes">aceA</italic> (BMEI0409) and malate synthase <italic toggle="yes">glcB</italic> (BMEI0380), are not predicted to be essential <italic toggle="yes">in vivo</italic>, data in agreement with previous results in <italic toggle="yes">B</italic>. <italic toggle="yes">abortus</italic> [<xref rid="ppat.1012459.ref049" ref-type="bibr">49</xref>] and <italic toggle="yes">B</italic>. <italic toggle="yes">suis</italic> [<xref rid="ppat.1012459.ref048" ref-type="bibr">48</xref>,<xref rid="ppat.1012459.ref051" ref-type="bibr">51</xref>]</p>
      <p>Also, the Tn-seq data predict that the glutamate synthase (GOGAT) enzyme, formed by <italic toggle="yes">gltB</italic> (BMEII0040) and <italic toggle="yes">gltD</italic> (BMEII0039), is essential during <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M multiplication in the spleen. GS-GOGAT is a two reaction-cycle that incorporates ammonium into glutamate to obtain glutamine (glutamine synthetase, GS), followed by the transfer of the amide group into a-ketoglutarate by GOGAT, with an overall yield of one glutamate molecule. In line with these results, mutants in <italic toggle="yes">gltB</italic> and <italic toggle="yes">gltD</italic> are attenuated both in cells and mice [<xref rid="ppat.1012459.ref052" ref-type="bibr">52</xref>,<xref rid="ppat.1012459.ref053" ref-type="bibr">53</xref>] These results might indicate that, although glutamine/glutamate are critical because they serve as the N donor for the biosynthesis of most amino acids, amino sugars, purines, pyrimidines, NAD+ and p-aminobenzoate [<xref rid="ppat.1012459.ref054" ref-type="bibr">54</xref>], they are not provided in sufficient amounts in the infected cells of the spleen.</p>
      <p>Collectively, these Tn-seq data suggest that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> could face multiple nutritional stresses in mice, which is consistent with its intracellular localization in activated phagocytic cells. <italic toggle="yes">In vivo</italic>, <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> seems to have to synthesize histidine and adenine itself and import methionine. It also seems to be dealing with glucose deprivation. In keeping with these hypotheses, activation of the MyD88 pathway in macrophages has been shown to promote M1 metabolic polarization favoring glycolysis and glucose consumption able to directly restrict <italic toggle="yes">Brucella</italic> proliferation [<xref rid="ppat.1012459.ref055" ref-type="bibr">55</xref>]. Thus, in an M1 polarized intracellular environment low in glucose, we hypothesize that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> would use amino acid such as glutamate and glutamine as well as fatty acids from the host cells to allow LPS biosynthesis and production of essential amino acids like histidine. In support of this, we previously showed by fluorescent microscopic analysis that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> host cells in the spleen of IL-12<sup>-/-</sup> BALB/c mice are particularly lipid-rich [<xref rid="ppat.1012459.ref023" ref-type="bibr">23</xref>]. It is not known whether <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> has access to large quantities of glutamine within its replication niche <italic toggle="yes">in vivo</italic>. However, glutamine is an amino acid that is very abundant in mammals and fuels many tissues as well as immune system cells [<xref rid="ppat.1012459.ref056" ref-type="bibr">56</xref>]. It is one of the most abundant amino acids in the THP-1 macrophage cell line [<xref rid="ppat.1012459.ref057" ref-type="bibr">57</xref>]. Glutamine is a favored source of nitrogen and, for example, is required for adenine biosynthesis via the PurA,B,C,E,H,Q,S enzymes. Glutamine can be also used to produce glutamate via GOGAT [<xref rid="ppat.1012459.ref042" ref-type="bibr">42</xref>] or, possibly, via a glutaminase <italic toggle="yes">purQ</italic> (BMEI1124). The latter was functionally identified as a glutaminase in <italic toggle="yes">Bacillus subtilis</italic> [<xref rid="ppat.1012459.ref058" ref-type="bibr">58</xref>]. Glutamate can be consumed by the TCA cycle to produce pyruvate and ultimately glucose (<xref rid="ppat.1012459.g006" ref-type="fig">Fig 6</xref>). In addition, in several bacteria, glutamate metabolism has been implicated in the resistance of bacteria to acid stress [<xref rid="ppat.1012459.ref059" ref-type="bibr">59</xref>]. The glutamate decarboxylase (GAD) system facilitates intracellular pH homoeostasis by consuming protons in a decarboxylation reaction that produces c-aminobutyrate (GABA) from glutamate. However, <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> strains do not have a functional GAD system [<xref rid="ppat.1012459.ref060" ref-type="bibr">60</xref>].</p>
      <p>Comparison of our Tn-seq data obtained in the lungs and spleen demonstrates that several sets of genes are specifically required for <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the lungs or spleen. Among the 12 genes predicted to be essential in the lungs and not in the spleen, a clustering analysis identified a cluster involved in tryptophan synthesis, a cluster associated with polymyxin resistance, and a cluster associated with respiration that are indispensable in the lungs and not in the spleen (<xref rid="ppat.1012459.g003" ref-type="fig">Fig 3A</xref>). It is well described that the innate immune response depletes cellular tryptophan in response to infection via the host enzyme indoleamine 2,3-dioxygenase (IDO-1) that converts tryptophan to N-formylkynurenine, which is a potent negative regulator of inflammation. The tryptophan biosynthetic pathway has been shown to be essential for host colonization by <italic toggle="yes">Mycobacterium tuberculosis</italic>. &#x394;<italic toggle="yes">trpD M</italic>. <italic toggle="yes">tuberculosis</italic> failed to cause disease in both wild-type and severe combined immune-deficient (SCID) mice [<xref rid="ppat.1012459.ref061" ref-type="bibr">61</xref>]. The <italic toggle="yes">bveA</italic> (BMEII0681) gene of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> encodes a phospholipase A1 with specificity for phosphatidylethanolamine (PE). By reducing the level of PE in the bacterial membrane, <italic toggle="yes">bveA</italic> increases the resistance of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> to polymyxin and is required for persistent infection in mice [<xref rid="ppat.1012459.ref062" ref-type="bibr">62</xref>]. To our knowledge, the importance of <italic toggle="yes">ctaA</italic> (BMEI1172), a heme A synthase, and <italic toggle="yes">ctaG</italic> (BMEI1463), a cytochrome c oxidase assembly protein, in mice has not been described.</p>
      <p>Among the 34 genes predicted to be essential in the spleen and not in the lungs, a clustering analysis identified only four small clusters (<xref rid="ppat.1012459.g003" ref-type="fig">Fig 3B</xref>): one cluster associated with amino acid biosynthesis, one identified as a zinc transporter, one identified as an efflux transporter and one identified as an ABC transporter. The other 23 genes could not be linked to a gene cluster and 5 of them are unidentified. Zinc (Zn<sup>2+</sup>) is an essential metal required by bacteria as either a structural or catalytic cofactor but free Zn<sup>2+</sup> concentrations in mammalian hosts are very low. The <italic toggle="yes">znuABC</italic> operon constitutes a high-affinity periplasmic binding protein-dependent ATP-binding cassette (ABC) transport system used by bacteria for the uptake of Zn<sup>2+</sup>. It has been reported that &#x394;<italic toggle="yes">znuA B</italic>. <italic toggle="yes">melitensis</italic> [<xref rid="ppat.1012459.ref063" ref-type="bibr">63</xref>] and &#x394;<italic toggle="yes">znuA B</italic>. <italic toggle="yes">abortus</italic> [<xref rid="ppat.1012459.ref064" ref-type="bibr">64</xref>] are attenuated in the spleen of BALB/c mice.</p>
      <p>Taken together, these results suggest that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> faces different nutritional conditions in the lungs and spleen. In particular, <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> is thought to face deprivation of tryptophan in the lungs and of Zn<sup>2+</sup> in the spleen. We confirmed using deletion mutants that the <italic toggle="yes">trpD</italic> (BMEI0844) gene is essential in the lungs and not in the spleen and that the <italic toggle="yes">znuA</italic> (BMEII0178) gene is essential in the spleen and not in the lungs.</p>
      <p>The fact that persistence of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the lungs and spleen requires specific sets of genes suggests that it should be possible to use our Tn-seq data to develop vaccine candidates capable of persisting in organs long enough to induce development of a protective immune memory but unable to colonize the reservoir of the spleen on a long-term basis. Using these criteria (summarized in <xref rid="ppat.1012459.g009" ref-type="fig">Fig 9</xref>), we selected two candidate genes, <italic toggle="yes">murI</italic> (BMEI0795) and <italic toggle="yes">plsC</italic> (BMEI1977). We predicted that inactivation of <italic toggle="yes">murI</italic> would induce very strong attenuation of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the spleen and that inactivation of <italic toggle="yes">plsC</italic> would result in moderate attenuation. We constructed deletion mutants of these genes and validated our Tn-seq predictions.</p>
      <p>To our knowledge, <italic toggle="yes">murI</italic> and <italic toggle="yes">plsC</italic> have not been characterized in <italic toggle="yes">Brucella</italic> spp. The <italic toggle="yes">murI</italic> gene is predicted to code for a glutamate racemase, an enzyme involved in peptidoglycan (PG) biosynthesis. By converting L-glutamate to D-glutamate, this enzyme participates in the synthesis of peptide stems of PG, and thus contributes more generally to the integrity and growth of the bacteria [<xref rid="ppat.1012459.ref065" ref-type="bibr">65</xref>]. In the literature, the <italic toggle="yes">murI</italic> gene is known to be the only enzyme that is able to synthesize D-Glu in <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> [<xref rid="ppat.1012459.ref066" ref-type="bibr">66</xref>] and <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> [<xref rid="ppat.1012459.ref067" ref-type="bibr">67</xref>] and is essential for their growth <italic toggle="yes">in vitro</italic>. The <italic toggle="yes">plsC</italic> gene coding for the integral membrane protein PlsC, an Acyl-sn-glycerol-3-phosphate acyltransferase. In mammals, PlsC enzyme is involved in phospholipid biosynthesis and is therefore required for epidermal permeability barrier homeostasis [<xref rid="ppat.1012459.ref068" ref-type="bibr">68</xref>]. It could be hypothesized that inactivation of <italic toggle="yes">plsC</italic> in <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> might change the properties of inner and outer membrane, potentially having pleiotropic effects on mechanisms such as effector secretion, resistance to antimicrobial peptides or alterations in the ability of the bacterium to adapt to environmental changes such as variations in acidity and osmolarity. Identifying the mechanisms explaining attenuation of &#x394;<italic toggle="yes">plsC B</italic>. <italic toggle="yes">melitensis</italic> strain in mice is difficult work that is beyond the scope of our study.</p>
      <p>We compared the ability of deletion mutants for the <italic toggle="yes">murI</italic> and <italic toggle="yes">plsC</italic> genes to induce protective immunity in wild-type C57BL/6 mice. Surprisingly, we observed that the strongly attenuated &#x394;<italic toggle="yes">murI</italic> strain induces only weak immunity in the lungs and spleen (-1 log CFU) whereas the moderately attenuated &#x394;<italic toggle="yes">plsC</italic> strain induces immunity similar to the wild-type and Rev.1 strains. These results suggest that it is essential for the vaccine strain to be able to multiply in the lungs and the spleen to induce the development of protective immunity in these organs. Excessive attenuation prevents activation of the immune system. This suggests that the activation of adaptive immunity by <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> indeed requires the completion of an infection cycle, and that the simple administration of antigens is ineffective in protecting the animal. These results can be correlated with the induction of specific <italic toggle="yes">Brucella</italic> IgG2a antibodies. Protective wild type, &#x394;<italic toggle="yes">plsC</italic> and Rev.1 strains induce high levels of antibodies while non-protective strains such as &#x394;<italic toggle="yes">virB</italic> and &#x394;<italic toggle="yes">murI</italic> strains do not. Very interestingly, we observed that persistence of the &#x394;<italic toggle="yes">plsC</italic> strain in mice at 28 days post-vaccination was lower than that of the Rev.1 strain, suggesting that the &#x394;<italic toggle="yes">plsC</italic> strain may be safer than the Rev.1 strain.</p>
      <p>Our approach has several limitations. First, <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> can infect and persist in many organs <italic toggle="yes">in vivo</italic> and we only analyzed two of them in C57BL/6 mice. A more extensive functional map, including other organs of interest, such as the lymph nodes and placenta, would be useful to better understand the biology of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in the mouse model. Secondly, it is not advisable to make attenuation of a vaccine dependent on the deletion of a single gene. Consequently, it would be useful to carry out new Tn-Seq analyses in the organs of interest using a library constructed from the &#x394;<italic toggle="yes">plsC</italic> strain and to compare these results to those already available with the library constructed from the wild-type strain. This approach would identify other genes that can be deleted without the risk of excessively reducing the virulence of the vaccine candidate in the spleen, while guaranteeing the desired level of attenuation. Thirdly, since mice are not the natural host of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> and in light of the fact that many vaccines developed in mice have failed to induce immunity in cattle, Tn-seq analyses should be carried out in the spleen of goats or sheep in order to validate the results obtained in mice.</p>
      <p>Overall, our results demonstrate that <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> faces very different environments <italic toggle="yes">in vivo</italic> depending on the organs infected. Identifying the nutritional requirements of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis in vivo</italic> may open up new avenues for brucellosis treatment. For example, tryptophan synthase inhibitors from <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> have been developed and have been shown to be effective in blocking its growth [<xref rid="ppat.1012459.ref069" ref-type="bibr">69</xref>]. Our results also show that the construction of a functional map of the <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genome using Tn-seq analyses carried out on different organs can be a valuable aid for the development of effective attenuated vaccine candidates in mice, with a safer profile.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec008">
      <title>Materials and methods</title>
      <sec id="sec009">
        <title>Ethics statement</title>
        <p>The procedures used in this study and the handling of the mice complied with current European legislation (Directive 86/609/EEC). The Animal Welfare Committee of the Universit&#xE9; de Namur (UNamur, Belgium) reviewed and approved the complete protocol for <italic toggle="yes">Brucella melitensis</italic> infection (Permit Number: UN-LE-18/309 and UN-LE-23/401).</p>
      </sec>
      <sec id="sec010">
        <title>Mice and bacterial strains</title>
        <p>Wild-type C57BL/6 mice were acquired from Harlan (Bicester, UK). IFN-&#x3B3;R<sup>-/-</sup> C57BL/6 mice [<xref rid="ppat.1012459.ref017" ref-type="bibr">17</xref>] were acquired from Dr B. Ryffel (University of Orleans, France). All wild-type and deficient mice used in this study were bred in the animal facility of the Gosselies campus of the Universit&#xE9; Libre de Bruxelles (ULB, Belgium).</p>
        <p>The wild-type <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M strain used here is a Nal<sup>R</sup> derivative of wild-type <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M [<xref rid="ppat.1012459.ref070" ref-type="bibr">70</xref>]. We also used wild-type [<xref rid="ppat.1012459.ref022" ref-type="bibr">22</xref>] and &#x394;<italic toggle="yes">virB</italic>1-12 (BMEII0025-35) [<xref rid="ppat.1012459.ref071" ref-type="bibr">71</xref>] <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M strains stably expressing the mCherry fluorescent protein under the control of the strong <italic toggle="yes">Brucella</italic> spp. promoter p<sub><italic toggle="yes">secE</italic></sub>, also called p<sub>sog</sub> or p<sub><italic toggle="yes">sojA</italic></sub> [<xref rid="ppat.1012459.ref072" ref-type="bibr">72</xref>]. <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> Rev.1 is the World Organisation for Animal Health (WOAH) recommended goat and sheep brucellosis vaccine and was obtained from Sciensano (Belgium).</p>
        <p><italic toggle="yes">Brucella melitensis</italic> was always handled in BSL-3 containment facilities according to Council Directive 98/81/EC of 26 October 1998 and the law of the Walloon government of 4 July 2002.</p>
      </sec>
      <sec id="sec011">
        <title>Transposon mutagenesis</title>
        <p>One milliliter of an overnight culture of a nalidixic acid-resistant strain of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M was mixed with 50 &#x3BC;L of an overnight culture of the conjugative <italic toggle="yes">Escherichia coli</italic> S17-1 strain carrying the pXMCS-2 mini-Tn<italic toggle="yes">5</italic> Kan<sup>r</sup> plasmid [<xref rid="ppat.1012459.ref073" ref-type="bibr">73</xref>]. This plasmid possesses a hyperactive Tn<italic toggle="yes">5</italic> transposase allowing for straightforward generation of a high number of Tn mutants, as described previously [<xref rid="ppat.1012459.ref073" ref-type="bibr">73</xref>]. The mating mixture was incubated overnight at room temperature (RT) on 2YT agar plates (rich medium, 1% yeast extract, 1.6% peptone, 0.5% NaCl, 2% agar). The resulting <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> Tn mutants were selected on 2YT agar plates supplemented with both kanamycin (10 &#x3BC;g/mL) and nalidixic acid (25 &#x3BC;g/mL). Tn<italic toggle="yes">5</italic> mutagenesis generates insertion of the transposon at only one locus per genome, as demonstrated previously for <italic toggle="yes">Brucella</italic> [<xref rid="ppat.1012459.ref074" ref-type="bibr">74</xref>].</p>
      </sec>
      <sec id="sec012">
        <title>Analysis of essential genes for growth on plates</title>
        <p>Genomic DNA was extracted from a spleen transposon library using standard techniques and prepared for transposon library sequencing. Briefly, <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> Tn mutants from each plate were collected, mixed and killed by heat (1 hour, 80&#xB0;C). The lysate was incubated with a mixture composed of Tris (tris-hydroxymethyl-aminomethane 50 mM), EDTA (Ethylenediaminetetraacetic acid, 50 mM), 0.1 M NaCl, Proteinase K (20 mg/mL) and 10% SDS. The mixture was treated with an equal volume of 100% isopropanol to precipitate the DNA, which was washed with 70% ethanol. Genomic DNA was resuspended in deionized water and genomic DNA flanking the Tn<italic toggle="yes">5</italic> was sequenced (Fasteris company, Geneva, Switzerland). Libraries were sequenced on an <bold>Illumina HiSeq</bold> (for spleen from IFN&#x3B3;R<sup>-/-</sup> mice conditions) or on an <bold>Illumina NextSeq</bold> (for 2YT, lung and spleen from wild-type mice conditions) with a primer hybridized at the border of the transposon, with its 3&#x2019; end pointing toward the flanking genomic DNA. Raw reads for each biological conditions (available at <ext-link xlink:href="https://doi.org/10.6084/m9.figshare.26063158.v1" ext-link-type="uri">https://doi.org/10.6084/m9.figshare.26063158.v1</ext-link>) were mapped on <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M (accession numbers NC_003317 and NC_003318 for chromosomes I and II, respectively) using BWA [<xref rid="ppat.1012459.ref075" ref-type="bibr">75</xref>] and read counts were determined using the samtools suite [<xref rid="ppat.1012459.ref076" ref-type="bibr">76</xref>]. To account for truncated but functional products and misannotated start sites, only insertions in the central 80% of each gene were considered.</p>
        <p>To determine if an insertional mutant in a defined gene is affected in a condition but untouched in the control 2YT condition, each gene was assigned an insertion index, called the <bold>transposon insertion frequency</bold> (<bold>TnIF</bold>), equal to the log<sub>10</sub> of its total read count (thus including multiple insertions at the same position) +1, divided by its length (in bp), corresponding to 80% of the internal segment of the coding sequence. For each gene, a &#x394;TnIF (TnIF<sub>cdt</sub>&#x2212;TnIF<sub>CTRL</sub>) value was calculated, where TnIF was computed for the tested condition (TnIF<sub>cdt</sub>) and the control condition (TnIF<sub>CTRL</sub>). The frequency distribution of &#x394;TnIF values was plotted for both chromosomes and for each condition tested (<xref rid="ppat.1012459.s003" ref-type="supplementary-material">S3 Fig</xref>), to identify the main peak of unaffected &#x394;TnIF values and its standard deviation. 2% of &#x394;TnIF values at each extremity were removed to avoid an influence of extreme values. The standard deviation was calculated on this distribution. Depending on the conditions tested, the standard deviation ranged from 0.19 and 0.30 with a mean of 0.24. The &#x394;TnIF values greater than 0.5 were thus selected as significant, since they correspond to 1.6 to 2.6 standard deviations from the mode, designating genes for which the TnIF value was decreased compared to the control condition.</p>
      </sec>
      <sec id="sec013">
        <title>Construction of deletion mutants to test Tn-seq predictions</title>
        <p>Construction of the &#x394;<bold><italic toggle="yes">trpD</italic></bold> (BMEI0843) and &#x394;<bold><italic toggle="yes">gmd</italic></bold> (BMEI1413) <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M strains has been previously described [<xref rid="ppat.1012459.ref016" ref-type="bibr">16</xref>]. The &#x394;<bold><italic toggle="yes">lysR</italic></bold> (BMEI0513), &#x394;<bold><italic toggle="yes">murI</italic></bold> (BMEI0795), &#x394;<bold><italic toggle="yes">plsC</italic></bold> (BMEI1977), &#x394;<bold><italic toggle="yes">purH</italic></bold> (BMEI0233) and &#x394;<bold><italic toggle="yes">znuA</italic></bold> (BMEII0178) deletion strains were constructed in the <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M wt strain by triparental mating to introduce the pNPTS138 Kan<sup>R</sup> plasmid (containing the upstream joined to the downstream region, generated by PCR, for the respective genes of interest for deletion) in the <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M Nal strain using the <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> MT 607 (<italic toggle="yes">pro-82 thi-I hsdR17</italic> (r-m+) <italic toggle="yes">supE44 recA56</italic> pRK600) strain (as described in [<xref rid="ppat.1012459.ref077" ref-type="bibr">77</xref>]), and allelic replacement was performed as described previously for other gene deletions [<xref rid="ppat.1012459.ref078" ref-type="bibr">78</xref>]. These mutant strains do not have inserted antibiotic resistance genes.</p>
        <p>&#x394;<italic toggle="yes">gmd</italic>, &#x394;<italic toggle="yes">lysR</italic>, &#x394;<italic toggle="yes">murI</italic>, &#x394;<italic toggle="yes">plsC</italic>, &#x394;<italic toggle="yes">purH</italic>, &#x394;<italic toggle="yes">trpD</italic> and &#x394;<italic toggle="yes">znuA</italic> deletion strains were conjugated with <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> S17-1 containing the pSK kanR DsRed plasmid to introduce genes for kanamycin resistance and to express DsRed. Deletion of the genes was checked using the respective primers: the lysR-CheckF and lysR-CheckR primers for <italic toggle="yes">lysR</italic>, the murI-CheckF and murI-CheckR primers for <italic toggle="yes">murI</italic>, the plsC-CheckF and plsC-CheckR primers for <italic toggle="yes">plsC</italic>, purH-CheckF and purH-CheckF primers for <italic toggle="yes">purH</italic>, the znuA-CheckF and znuA-CheckR primers for <italic toggle="yes">znuA</italic>. See <xref rid="ppat.1012459.s006" ref-type="supplementary-material">S3 Table</xref> for primer sequences used to amplify upstream and downstream regions of each gene.</p>
        <p>The &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> deletion mutants were complemented with the pMR10 vector containing the gene corresponding amplified with primers, as listed in <xref rid="ppat.1012459.s006" ref-type="supplementary-material">S3 Table</xref>, under the control of the p<sub><italic toggle="yes">lac</italic></sub> promoter (pMR10::<italic toggle="yes">trpD</italic>, pMR10::<italic toggle="yes">murI</italic>).</p>
      </sec>
      <sec id="sec014">
        <title><italic toggle="yes">Brucella melitensis</italic> infection in vivo</title>
        <p>Mice were anesthetized with a cocktail of Xylazine (9 mg/kg) and Ketamine (36 mg/kg) in PBS before being inoculated by intranasal injection with 10<sup>5</sup> or 5 &#xD7; 10<sup>6</sup> CFU of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in 30 &#x3BC;L of RPMI, as indicated. Intraperitoneal injection of 5 &#xD7; 10<sup>6</sup> CFU of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> in 500 &#x3BC;L of RPMI was performed without anesthesia as described previously [<xref rid="ppat.1012459.ref027" ref-type="bibr">27</xref>]. Control animals were inoculated with the same volume of RPMI. We used a mCherry-expressing wild-type (wt) 16M strain [<xref rid="ppat.1012459.ref079" ref-type="bibr">79</xref>], mCherry-expressing &#x394;<italic toggle="yes">virB</italic> 16M strain [<xref rid="ppat.1012459.ref022" ref-type="bibr">22</xref>] or DsRed-expressing gene deletion mutants in the wild-type <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> 16M background as indicated for the infections. Cultures were grown overnight with shaking at 37&#xB0;C in 2YT medium and were washed twice in RPMI 1640 (Gibco Laboratories) (3500 g, 10 min) before inoculation in the mice. The infectious doses were validated by plating serial dilutions of the inoculums. At the selected times after infection, mice were sacrificed by cervical dislocation. Immediately after sacrifice, spleen and/or lung cells were collected for bacterial counting or bacterial DNA extraction. All infections were performed in an Animal Biosafety Level 3 facility.</p>
        <p>For bacterial counting, organs were homogenized in PBS/0.1% X-100 Triton (Sigma-Aldrich). We performed successive serial dilutions in RPMI to obtain the most accurate bacterial count and plated them on 2YT medium. The CFU were counted after 4 days of incubation at 37&#xB0;C.</p>
      </sec>
      <sec id="sec015">
        <title>Protocol for secondary infection with <italic toggle="yes">Brucella melitensis</italic></title>
        <p>C57BL/6 mice were immunized intranasally (i.n.) with 10<sup>5</sup> CFU of live wild-type or deletion mutants of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensi</italic>s 16M, as indicated. The infectious doses were validated by plating serial dilutions of inoculums. Six weeks after immunization, the mice were challenged i.n. with 10<sup>5</sup> CFU of live wild-type mCherry-<italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> and sacrificed at 12 days post-infection. It is important to note that none of the strains used for vaccination has Kan resistance or expresses a fluorochrome. The expression of Kan resistance and the mCherry fluorochrome by the challenge strain makes it possible to easily differentiate the vaccine strains from the challenge strain when counting the bacterial colonies on plates of 2YT-Agar medium with or without kanamycin (50 &#x3BC;g/mL) since bacteria with mCherry form pink colonies on plates.</p>
      </sec>
      <sec id="sec016">
        <title>Enzyme-linked immunosorbent assay (ELISA)</title>
        <p>The presence of <italic toggle="yes">Brucella melitensis</italic> specific murine IgG2a was determined by ELISA. Polystyrene plates (269620; Nunc) were coated with Heat Killed (HK) <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> (10<sup>7</sup> CFU/mL) and incubated overnight at 4&#xB0;C. The plates were blocked for 2 hours at RT with 200 &#x3BC;L/well of PBS-1% Bovine Serum Albumin (BSA). Then, plates were incubated with 50 &#x3BC;L/well of plasma in serial dilutions in PBS-0.1% BSA. The plasma of uninfected mice and PBS were used as negative controls. After four washes with PBS, isotype-specific goat anti-mouse HRP-conjugated Ab were added (50 &#x3BC;L/well) at appropriated dilutions (LO-MG2a-9 HRPO from LOIMEX). After 1 hour of incubation at RT, plates were washed four times in PBS and 100 &#x3BC;L/well of TMB substrate solution (BD OptEiA Kit) was added. After 15 minutes of incubation at RT in the dark, the enzyme reaction was stopped by adding 25 &#x3BC;L/well of 2 N H<sub>2</sub>SO<sub>4</sub>. The absorbance was measured at 450 nm.</p>
      </sec>
      <sec id="sec017">
        <title>Statistical analysis</title>
        <p>We used a (Wilcoxon-)Mann-Whitney test provided by the GraphPad Prism software to statistically analyze our results. Each group of deficient mice was compared with the wild-type mice. We also compared each group with the other groups and displayed the results when required. Values of p &lt; 0.05 were considered to represent a significant difference. *, **, *** denote p &lt; 0.05, p &lt; 0.01, p &lt; 0.001, respectively.</p>
      </sec>
    </sec>
    <sec id="sec018" sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material id="ppat.1012459.s001" position="float" content-type="local-data">
        <label>S1 Fig</label>
        <caption>
          <title>Complementation of &#x394;<italic toggle="yes">murI</italic> and &#x394;<italic toggle="yes">plsC</italic> in the lungs and spleen.</title>
          <p>Data shown are bacterial counts (CFU) at the 120 hours post-infection in the lungs (<bold>A</bold>) and spleen (<bold>B</bold>) from wild-type mice infected intranasally (<bold>A</bold>) or intraperitoneally (<bold>B</bold>) with wild-type (wt), &#x394;<italic toggle="yes">murI</italic> or &#x394;<italic toggle="yes">murI</italic>-complemented, &#x394;<italic toggle="yes">plsC</italic> or &#x394;<italic toggle="yes">plsC</italic>-complemented strains of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> at a dose of 5x10<sup>6</sup> CFU. Red lines represent the geometric mean. Dotted lines represent the mean of the wild-type strain. Significant differences between wt and the indicated groups are marked with asterisks: *p &lt; 0.1, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001, in a (Wilcoxon-)Mann-Whitney post-test. These results are representative of two independent experiments.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="ppat.1012459.s001.tif"/>
      </supplementary-material>
      <supplementary-material id="ppat.1012459.s002" position="float" content-type="local-data">
        <label>S2 Fig</label>
        <caption>
          <title>Humoral immune response induced by intranasal <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> strains infection.</title>
          <p>Wild-type C57BL/6 mice were infected intranasally with a dose of 10<sup>5</sup> CFU of several strains of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> (wild-type (WT), &#x394;<italic toggle="yes">plsC</italic>, Rev.1, &#x394;<italic toggle="yes">murI</italic> or &#x394;<italic toggle="yes">virB</italic>). Sera were collected at 5 weeks post-infection, and ELISA was performed to determine the isotype distribution of the IgG2a <italic toggle="yes">Brucella</italic>-specific antibodies. The data represent the means &#xB1; SD of the results. O.D, optical density. These results are representative of two independent experiments.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="ppat.1012459.s002.tif"/>
      </supplementary-material>
      <supplementary-material id="ppat.1012459.s003" position="float" content-type="local-data">
        <label>S3 Fig</label>
        <caption>
          <title>Frequency distribution of &#x394;TnIF values of genes from chromosomes I and II of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> for each tested <italic toggle="yes">in vivo</italic> condition.</title>
          <p>For each condition (lungs, spleen, spleen from IFN-&#x3B3;<sup>-/-</sup>), the &#x394;TnIF values are represented by classes of 0.2. The blue histogram shows the distribution for &#x394;TnIF values for all genes that are untouched in the control 2YT condition. The red color represents the distribution for &#x394;TnIF values without 2% of the genes at each extremity. SD = standard deviation.</p>
          <p>(PDF)</p>
        </caption>
        <media xlink:href="ppat.1012459.s003.pdf"/>
      </supplementary-material>
      <supplementary-material id="ppat.1012459.s004" position="float" content-type="local-data">
        <label>S1 Table</label>
        <caption>
          <title>List of attenuated <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes <italic toggle="yes">in vitro</italic> and in mice conditions.</title>
          <p><bold>Page 1</bold>: List of the 3369 genes of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic>. Each gene is associated with the value of TnIF in the 2YT, lungs and spleen conditions as well as the value of &#x394;TnIF associated with the lungs and spleen conditions. <bold>Page 2</bold>: List of 2460 genes that are not predicted to induce a growth defect in 2YT (TnIF &gt; 2.7 in 2YT condition). <bold>Page 3</bold>: List of 135 genes predicted to cause attenuation in the lungs of wild type mice (&#x394;TnIF &lt; -0.5 in lungs condition). <bold>Page 4</bold>: List of 257 genes predicted to cause attenuation in the spleen of wild type mice (&#x394;TnIF &lt; -0.5 in spleen condition). <bold>Page 7</bold>: List of the 4 genes selected as vaccine candidates showing strong attenuation in the spleen (dTnIF &lt; -2.0 in spleen condition). <bold>Page 8</bold>: List of the 17 genes selected as vaccine candidates showing moderate attenuation in the spleen (dTnIF &lt; -1.0).</p>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="ppat.1012459.s004.xlsx"/>
      </supplementary-material>
      <supplementary-material id="ppat.1012459.s005" position="float" content-type="local-data">
        <label>S2 Table</label>
        <caption>
          <title>List of <italic toggle="yes">B</italic>. <italic toggle="yes">melitensis</italic> genes that are predicted as attenuated in the spleen of wild-type mice but that are predicted as not attenuated in the spleen of IFN&#x3B3;R<sup>-/-</sup> mice.</title>
          <p>Bacterial genes required to grow in the spleen of wild-type (wt) mice infected intraperitoneally (&#x394;TnIF &lt; -1.0) and that are not attenuated in the spleen of IFN&#x3B3;R<sup>-/-</sup> mice infected by the same route (&#x394;TnIF &gt; -0.5). NA = not assigned.</p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="ppat.1012459.s005.docx"/>
      </supplementary-material>
      <supplementary-material id="ppat.1012459.s006" position="float" content-type="local-data">
        <label>S3 Table</label>
        <caption>
          <title>List of primers used in the construction of deletion mutants and for complementation of mutants.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="ppat.1012459.s006.docx"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank K. Willemart, F. Tilquin, E. Carlier and M. Waroquier for their technical support.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="ppat.1012459.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Martirosyan</surname><given-names>A</given-names></name>, <name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Gorvel</surname><given-names>JP</given-names></name>. <article-title>An evolutionary strategy for a stealthy intracellular Brucella pathogen</article-title>. <source>Immunological Reviews</source>. <year>2011</year>. pp. <fpage>211</fpage>&#x2013;<lpage>234</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1600-065X.2010.00982.x</pub-id>
<pub-id pub-id-type="pmid">21349096</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Atluri</surname><given-names>VL</given-names></name>, <name><surname>Xavier</surname><given-names>MN</given-names></name>, <name><surname>De Jong</surname><given-names>MF</given-names></name>, <name><surname>Den Hartigh</surname><given-names>AB</given-names></name>, <name><surname>Tsolis</surname><given-names>RM</given-names></name>. <article-title>Interactions of the human pathogenic Brucella species with their hosts</article-title>. <source>Annu Rev Microbiol</source>. <year>2011</year>;<volume>65</volume>: <fpage>523</fpage>&#x2013;<lpage>541</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev-micro-090110-102905</pub-id>
<pub-id pub-id-type="pmid">21939378</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Pappas</surname><given-names>G</given-names></name>, <name><surname>Papadimitriou</surname><given-names>P</given-names></name>, <name><surname>Akritidis</surname><given-names>N</given-names></name>, <name><surname>Christou</surname><given-names>L</given-names></name>, <name><surname>Tsianos</surname><given-names>E V</given-names></name>. <article-title>The new global map of human brucellosis</article-title>. <source>Lancet Infect Dis</source>. <year>2006</year>;<volume>6</volume>: <fpage>91</fpage>&#x2013;<lpage>99</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S1473-3099(06)70382-6</pub-id>
<pub-id pub-id-type="pmid">16439329</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>McDermott</surname><given-names>J</given-names></name>, <name><surname>Grace</surname><given-names>D</given-names></name>, <name><surname>Zinsstag</surname><given-names>J</given-names></name>. <article-title>Economics of brucellosis impact and control in low-income countries</article-title>. <source>OIE Rev Sci Tech</source>. <year>2013</year>;<volume>32</volume>: <fpage>249</fpage>&#x2013;<lpage>261</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.20506/rst.32.1.2197</pub-id>
<pub-id pub-id-type="pmid">23837382</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Lai</surname><given-names>S</given-names></name>, <name><surname>Zhou</surname><given-names>H</given-names></name>, <name><surname>Xiong</surname><given-names>W</given-names></name>, <name><surname>Gilbert</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>Z</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Changing epidemiology of human brucellosis, China, 1955&#x2013;2014</article-title>. <source>Emerg Infect Dis</source>. <year>2017</year>;<volume>23</volume>: <fpage>184</fpage>&#x2013;<lpage>194</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3201/eid2302.151710</pub-id>
<pub-id pub-id-type="pmid">28098531</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Laine</surname><given-names>CG</given-names></name>, <name><surname>Johnson</surname><given-names>VE</given-names></name>, <name><surname>Scott</surname><given-names>HM</given-names></name>, <name><surname>Arenas-Gamboa</surname><given-names>AM</given-names></name>. <article-title>Global Estimate of Human Brucellosis Incidence</article-title>. <source>Emerg Infect Dis</source>. <year>2023</year>;<volume>29</volume>: <fpage>1789</fpage>&#x2013;<lpage>1797</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3201/eid2909.230052</pub-id>
<pub-id pub-id-type="pmid">37610167</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Moriy&#xF3;n</surname><given-names>I</given-names></name>. <article-title>The Genus Brucella</article-title>. <source>The Prokaryotes</source>. <year>2006</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/0-387-30745-1_17</pub-id></mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Blasco</surname><given-names>JM</given-names></name>, <name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Mu&#xF1;oz</surname><given-names>PM</given-names></name>, <name><surname>C &#xC1;lvarez</surname><given-names>R</given-names></name>, <name><surname>Moriy&#xF3;n</surname><given-names>I</given-names></name>. <article-title>A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts</article-title>. <source>BMC Vet Res</source>. <year>2023</year>; <fpage>1</fpage>&#x2013;<lpage>21</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12917-023-03773-3</pub-id>
<pub-id pub-id-type="pmid">36597079</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Blasco</surname><given-names>JM</given-names></name>. <article-title>A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats</article-title>. <source>Prev Vet Med</source>. <year>1997</year>;<volume>31</volume>: <fpage>275</fpage>&#x2013;<lpage>283</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0167-5877(96)01110-5</pub-id>
<pub-id pub-id-type="pmid">9234451</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Ficht</surname><given-names>TA</given-names></name>, <name><surname>Kahl-McDonagh</surname><given-names>MM</given-names></name>, <name><surname>Arenas-Gamboa</surname><given-names>AM</given-names></name>, <name><surname>Rice-Ficht</surname><given-names>AC</given-names></name>. <article-title>Brucellosis: The case for live, attenuated vaccines</article-title>. <source>Vaccine</source>. <year>2009</year>;<volume>27</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.vaccine.2009.08.058</pub-id>
<pub-id pub-id-type="pmid">19837284</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Dorneles</surname><given-names>EMS</given-names></name>, <name><surname>Sriranganathan</surname><given-names>N</given-names></name>, <name><surname>Lage</surname><given-names>AP</given-names></name>. <article-title>Recent advances in Brucella abortus vaccines</article-title>. <source>Vet Res</source>. <year>2015</year>;<volume>46</volume>: <fpage>1</fpage>&#x2013;<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13567-015-0199-7</pub-id>
<pub-id pub-id-type="pmid">25582708</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref012">
        <label>12</label>
        <mixed-citation publication-type="book"><name><surname>Blasco</surname><given-names>J</given-names></name>, <name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Moriy&#xF3;n</surname><given-names>I</given-names></name>. <part-title>Brucellosis vaccines and vaccine candidates</part-title>. <edition designator="1">First Edit</edition>. In: <name><surname>Metwally</surname><given-names>S</given-names></name>, <name><surname>Viljoen</surname><given-names>G</given-names></name>, <name><surname>El Idrissi</surname><given-names>A</given-names></name>, editors. <source>Veterinary vaccines Principles and applications</source>. First Edit. <publisher-loc>Rome</publisher-loc>: <publisher-name>Hobeken</publisher-name>; <year>2021</year>. pp. <fpage>295</fpage>&#x2013;<lpage>316</lpage>.</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Blasco</surname><given-names>JM</given-names></name>, <name><surname>Molina-Flores</surname><given-names>B</given-names></name>. <article-title>Control and Eradication of Brucella melitensis Infection in Sheep and Goats</article-title>. <source>Vet Clin North Am&#x2014;Food Anim Pract</source>. <year>2011</year>;<volume>27</volume>: <fpage>95</fpage>&#x2013;<lpage>104</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cvfa.2010.10.003</pub-id>
<pub-id pub-id-type="pmid">21215893</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Van Opijnen</surname><given-names>T</given-names></name>, <name><surname>Camilli</surname><given-names>A</given-names></name>. <article-title>Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms</article-title>. <source>Nat Publ Gr</source>. <year>2013</year>;<volume>11</volume>: <fpage>435</fpage>&#x2013;<lpage>442</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrmicro3033</pub-id>
<pub-id pub-id-type="pmid">23712350</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Kwon</surname><given-names>YM</given-names></name>, <name><surname>Ricke</surname><given-names>SC</given-names></name>, <name><surname>Mandal</surname><given-names>RK</given-names></name>. <article-title>Transposon sequencing: methods and expanding applications</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2015</year>;<volume>100</volume>: <fpage>31</fpage>&#x2013;<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00253-015-7037-8</pub-id>
<pub-id pub-id-type="pmid">26476650</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Potemberg</surname><given-names>G</given-names></name>, <name><surname>Demars</surname><given-names>A</given-names></name>, <name><surname>Barbieux</surname><given-names>E</given-names></name>, <name><surname>Galia</surname><given-names>M</given-names></name>, <name><surname>Lagneaux</surname><given-names>M</given-names></name>, <name><surname>Comein</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide analysis of Brucella melitensis genes required throughout intranasal infection in mice</article-title>. <source>PLOS Pathog</source>. <year>2022</year>;<volume>16</volume>: <fpage>e1010621</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.ppat.1010621</pub-id>
<pub-id pub-id-type="pmid">35771771</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Mambres</surname><given-names>DH</given-names></name>, <name><surname>MacHelart</surname><given-names>A</given-names></name>, <name><surname>Potemberg</surname><given-names>G</given-names></name>, <name><surname>De Trez</surname><given-names>C</given-names></name>, <name><surname>Ryffel</surname><given-names>B</given-names></name>, <name><surname>Letesson</surname><given-names>J-J</given-names></name>, <etal>et al</etal>. <article-title>Identification of immune effectors essential to the control of primary and secondary intranasal infection with brucella melitensis in mice</article-title>. <source>J Immunol</source>. <year>2016</year>;<volume>196</volume>:<fpage>3780</fpage>&#x2013;<lpage>3793</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4049/jimmunol.1502265</pub-id>
<pub-id pub-id-type="pmid">27036913</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref018">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Copin</surname><given-names>R</given-names></name>, <name><surname>De Baetselier</surname><given-names>P</given-names></name>, <name><surname>Carlier</surname><given-names>Y</given-names></name>, <name><surname>Letesson</surname><given-names>J-J</given-names></name>, <name><surname>Muraille</surname><given-names>E</given-names></name>. <article-title>MyD88-dependent activation of B220<sup>-</sup>CD11b<sup>+</sup>LY-6C <sup>+</sup> dendritic cells during Brucella melitensis infection</article-title>. <source>J Immunol</source>. <year>2007</year>;<volume>178</volume>: <fpage>5182</fpage>&#x2013;<lpage>5191</lpage>. 178/8/5182 [pii].<pub-id pub-id-type="pmid">17404301</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Grill&#xF3;</surname><given-names>M</given-names></name>, <name><surname>Blasco</surname><given-names>JM</given-names></name>, <name><surname>Gorvel</surname><given-names>JP</given-names></name>, <name><surname>Moriy&#xF3;n</surname><given-names>I</given-names></name>, <name><surname>Moreno</surname><given-names>E</given-names></name>. <source>What have we learned from brucellosis in the mouse model?</source>
<year>2012</year>; <fpage>1</fpage>&#x2013;<lpage>35</lpage>.</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Demars</surname><given-names>A</given-names></name>, <name><surname>Lison</surname><given-names>A</given-names></name>, <name><surname>Machelart</surname><given-names>A</given-names></name>, <name><surname>Van Vyve</surname><given-names>M</given-names></name>, <name><surname>Potemberg</surname><given-names>G</given-names></name>, <name><surname>Vanderwinden</surname><given-names>JJ-M</given-names></name>, <etal>et al</etal>. <article-title>Route of Infection Strongly Impacts the Host-Pathogen Relationship</article-title>. <source>Front Immunol</source>. <year>2019</year>;<volume>10</volume>: <fpage>1589</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fimmu.2019.01589</pub-id>
<pub-id pub-id-type="pmid">31354728</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Archambaud</surname><given-names>C</given-names></name>, <name><surname>Salcedo</surname><given-names>SP</given-names></name>, <name><surname>Lelouard</surname><given-names>H</given-names></name>, <name><surname>Devilard</surname><given-names>E</given-names></name>, <name><surname>De Bovis</surname><given-names>B</given-names></name>, <name><surname>Van Rooijen</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Contrasting roles of macrophages and dendritic cells in controlling initial pulmonary Brucella infection</article-title>. <source>Eur J Immunol</source>. <year>2010</year>;<volume>40</volume>: <fpage>3458</fpage>&#x2013;<lpage>3471</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/eji.201040497</pub-id>
<pub-id pub-id-type="pmid">21108467</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Copin</surname><given-names>R</given-names></name>, <name><surname>Vitry</surname><given-names>M-A</given-names></name>, <name><surname>Hanot Mambres</surname><given-names>D</given-names></name>, <name><surname>Machelart</surname><given-names>A</given-names></name>, <name><surname>De Trez</surname><given-names>C</given-names></name>, <name><surname>Vanderwinden</surname><given-names>J-M</given-names></name>, <etal>et al</etal>. <article-title>In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice</article-title>. <source>PLoS Pathog</source>. <year>2012</year>;<volume>8</volume>: <fpage>e1002575</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.ppat.1002575</pub-id>
<pub-id pub-id-type="pmid">22479178</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Mambres</surname><given-names>DH</given-names></name>, <name><surname>Machelart</surname><given-names>A</given-names></name>, <name><surname>Vanderwinden</surname><given-names>JM</given-names></name>, <name><surname>De Trez</surname><given-names>C</given-names></name>, <name><surname>Ryffel</surname><given-names>B</given-names></name>, <name><surname>Letesson</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>In situ characterization of splenic brucella melitensis reservoir cells during the chronic phase of infection in susceptible mice</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>: <fpage>1</fpage>&#x2013;<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0137835</pub-id>
<pub-id pub-id-type="pmid">26376185</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Delrue</surname><given-names>RM</given-names></name>, <name><surname>Deschamps</surname><given-names>C</given-names></name>, <name><surname>L&#xE9;onard</surname><given-names>S</given-names></name>, <name><surname>Nijskens</surname><given-names>C</given-names></name>, <name><surname>Danese</surname><given-names>I</given-names></name>, <name><surname>Schaus</surname><given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>A quorum-sensing regulator controls expression of both the type IV secretion system and the flagellar apparatus of Brucella melitensis</article-title>. <source>Cell Microbiol</source>. <year>2005</year>;<volume>7</volume>: <fpage>1151</fpage>&#x2013;<lpage>1161</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00543.x</pub-id>
<pub-id pub-id-type="pmid">16008582</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref025">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Arocena</surname><given-names>GM</given-names></name>, <name><surname>Sieira</surname><given-names>R</given-names></name>, <name><surname>Comerci</surname><given-names>DJ</given-names></name>, <name><surname>Ugalde</surname><given-names>RA</given-names></name>. <article-title>Identification of the quorum-sensing target DNA sequence and N-acyl homoserine lactone responsiveness of the Brucella abortus virB promoter</article-title>. <source>J Bacteriol</source>. <year>2010</year>;<volume>192</volume>: <fpage>3434</fpage>&#x2013;<lpage>3440</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JB.00232-10</pub-id>
<pub-id pub-id-type="pmid">20400542</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Lacey</surname><given-names>CA</given-names></name>, <name><surname>Chambers</surname><given-names>CA</given-names></name>, <name><surname>Mitchell</surname><given-names>WJ</given-names></name>, <name><surname>Skyberg</surname><given-names>JA</given-names></name>. <article-title>IFN-&#x3B3;-dependent nitric oxide suppresses Brucella-induced arthritis by inhibition of inflammasome activation</article-title>. <source>Journal of Leukocyte Biology</source>. <year>2019</year>. pp. <fpage>27</fpage>&#x2013;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/JLB.4MIA1018-409R</pub-id>
<pub-id pub-id-type="pmid">30748031</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Vitry</surname><given-names>M-A</given-names></name>, <name><surname>De Trez</surname><given-names>C</given-names></name>, <name><surname>Goriely</surname><given-names>S</given-names></name>, <name><surname>Dumoutier</surname><given-names>L</given-names></name>, <name><surname>Akira</surname><given-names>S</given-names></name>, <name><surname>Ryffel</surname><given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice</article-title>. <source>Infect Immun</source>. <year>2012</year>;<volume>80</volume>: <fpage>4271</fpage>&#x2013;<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.00761-12</pub-id>
<pub-id pub-id-type="pmid">23006848</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Sheehan</surname><given-names>LM</given-names></name>, <name><surname>Budnick</surname><given-names>JA</given-names></name>, <name><surname>Blanchard</surname><given-names>C</given-names></name>, <name><surname>Dunman</surname><given-names>PM</given-names></name>, <name><surname>Caswell</surname><given-names>CC</given-names></name>. <article-title>A LysR-family transcriptional regulator required for virulence in Brucella abortus is highly conserved among the &#x3B1;-proteobacteria</article-title>. <source>Molecular Microbiology</source>. <year>2015</year>. pp. <fpage>318</fpage>&#x2013;<lpage>328</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/mmi.13123</pub-id>
<pub-id pub-id-type="pmid">26175079</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>ELBERG</surname><given-names>SS</given-names></name>, <name><surname>FAUNCE</surname><given-names>K</given-names></name>. <article-title>Immunization against Brucella infection. VI. Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of Brucella melitensis</article-title>. <source>J Bacteriol</source>. <year>1957</year>;<volume>73</volume>: <fpage>211</fpage>&#x2013;<lpage>217</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/jb.73.2.211-217.1957</pub-id>
<pub-id pub-id-type="pmid">13416171</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Schurig</surname><given-names>GG</given-names></name>, <name><surname>Sriranganathan</surname><given-names>N</given-names></name>, <name><surname>Corbel</surname><given-names>MJ</given-names></name>. <article-title>Brucellosis vaccines: Past, present and future</article-title>. <source>Vet Microbiol</source>. <year>2002</year>;<volume>90</volume>: <fpage>479</fpage>&#x2013;<lpage>496</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0378-1135(02)00255-9</pub-id>
<pub-id pub-id-type="pmid">12414166</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref031">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Alton</surname><given-names>GG</given-names></name>. <article-title>Control of brucella melitensis infection in sheep and goats-a review</article-title>. <source>Trop Anim Health Prod</source>. <year>1987</year>;<volume>19</volume>: <fpage>65</fpage>&#x2013;<lpage>74</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF02297320</pub-id>
<pub-id pub-id-type="pmid">3307078</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref032">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Banai</surname><given-names>M.</given-names></name>
<article-title>Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: Laboratory aspects and field observations</article-title>. <source>Vet Microbiol</source>. <year>2002</year>;<volume>90</volume>: <fpage>497</fpage>&#x2013;<lpage>519</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0378-1135(02)00231-6</pub-id>
<pub-id pub-id-type="pmid">12414167</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref033">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Higgins</surname><given-names>JL</given-names></name>, <name><surname>Gonzalez-juarrero</surname><given-names>M</given-names></name>, <name><surname>Bowen</surname><given-names>RA</given-names></name>. <source>Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1</source>. <year>2017</year>; <fpage>1</fpage>&#x2013;<lpage>16</lpage>.</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref034">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Blasco</surname><given-names>JM</given-names></name>, <name><surname>D&#xED;az</surname><given-names>R</given-names></name>. <article-title>Brucella melitensis Rev-1 vaccine as a cause of human brucellosis</article-title>. <source>Lancet</source>. <year>1993</year>;<volume>342</volume>: <fpage>805</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0140-6736(93)91571-3</pub-id>
<pub-id pub-id-type="pmid">8103891</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref035">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Vives-Soto</surname><given-names>M</given-names></name>, <name><surname>Puerta-Garc&#xED;a</surname><given-names>A</given-names></name>, <name><surname>Rodr&#xED;guez-S&#xE1;nchez</surname><given-names>E</given-names></name>, <name><surname>Pereira</surname><given-names>J</given-names></name>, <name><surname>Solera</surname><given-names>J</given-names></name>. <article-title>What risk do Brucella vaccines pose to humans? A systematic review of the scientific literature on occupational exposure</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2024</year>;<volume>18</volume>: <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pntd.0011889</pub-id>
<pub-id pub-id-type="pmid">38190394</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref036">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Salmon-Divon</surname><given-names>M</given-names></name>, <name><surname>Zahavi</surname><given-names>T</given-names></name>, <name><surname>Kornspan</surname><given-names>D</given-names></name>. <article-title>Transcriptomic analysis of the brucella melitensisrev.1 vaccine strain in an acidic environment: Insights into virulence attenuation</article-title>. <source>Front Microbiol</source>. <year>2019</year>;<volume>10</volume>: <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fmicb.2019.00250</pub-id>
<pub-id pub-id-type="pmid">30728808</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref037">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Gonz&#xE1;lez</surname><given-names>D</given-names></name>, <name><surname>Grill&#xF3;</surname><given-names>MJ</given-names></name>, <name><surname>De Miguel</surname><given-names>MJ</given-names></name>, <name><surname>Ali</surname><given-names>T</given-names></name>, <name><surname>Arce-Gorvel</surname><given-names>V</given-names></name>, <name><surname>Delrue</surname><given-names>RM</given-names></name>, <etal>et al</etal>. <article-title>Brucellosis vaccines: Assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export</article-title>. <source>PLoS One</source>. <year>2008</year>;<volume>3</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0002760</pub-id>
<pub-id pub-id-type="pmid">18648644</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref038">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Vitry</surname><given-names>M-A</given-names></name>, <name><surname>Hanot Mambres</surname><given-names>D</given-names></name>, <name><surname>Deghelt</surname><given-names>M</given-names></name>, <name><surname>Hack</surname><given-names>K</given-names></name>, <name><surname>Machelart</surname><given-names>A</given-names></name>, <name><surname>Lhomme</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Brucella melitensis invades murine erythrocytes during infection</article-title>. <source>Infect Immun</source>. <year>2014</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.01779-14</pub-id>
<pub-id pub-id-type="pmid">25001604</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref039">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Eisenschenk</surname><given-names>FC</given-names></name>, <name><surname>Houle</surname><given-names>JJ</given-names></name>, <name><surname>Hoffmann</surname><given-names>EM</given-names></name>. <article-title>Mechanism of serum resistance among Brucella abortus isolates</article-title>. <source>Vet Microbiol</source>. <year>1999</year>;<volume>68</volume>: <fpage>235</fpage>&#x2013;<lpage>244</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0378-1135(99)00075-9</pub-id>
<pub-id pub-id-type="pmid">10510042</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref040">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>CA</given-names></name>, <name><surname>Adams</surname><given-names>LG</given-names></name>, <name><surname>Ficht</surname><given-names>TA</given-names></name>. <article-title>Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival</article-title>. <source>Infect Immun</source>. <year>1998</year>;<volume>66</volume>: <fpage>1008</fpage>&#x2013;<lpage>1016</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.66.3.1008-1016.1998</pub-id>
<pub-id pub-id-type="pmid">9488389</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref041">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>De Tejada</surname><given-names>GM</given-names></name>, <name><surname>Pizarro-Cerda</surname><given-names>J</given-names></name>, <name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Moriyon</surname><given-names>I</given-names></name>. <article-title>The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides</article-title>. <source>Infect Immun</source>. <year>1995</year>;<volume>63</volume>: <fpage>3054</fpage>&#x2013;<lpage>3061</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/iai.63.8.3054-3061.1995</pub-id>
<pub-id pub-id-type="pmid">7622230</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref042">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Ronneau</surname><given-names>S</given-names></name>, <name><surname>Moussa</surname><given-names>S</given-names></name>, <name><surname>Barbier</surname><given-names>T</given-names></name>, <name><surname>Conde-&#xC1;lvarez</surname><given-names>R</given-names></name>, <name><surname>Zuniga-Ripa</surname><given-names>A</given-names></name>, <name><surname>Moriyon</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Brucella, nitrogen and virulence</article-title>. <source>Crit Rev Microbiol</source>. <year>2016</year>;<volume>42</volume>: <fpage>507</fpage>&#x2013;<lpage>525</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/1040841X.2014.962480</pub-id>
<pub-id pub-id-type="pmid">25471320</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref043">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Alcantara</surname><given-names>RB</given-names></name>, <name><surname>Read</surname><given-names>RDA</given-names></name>, <name><surname>Valderas</surname><given-names>MW</given-names></name>, <name><surname>Brown</surname><given-names>TD</given-names></name>, <name><surname>Roop</surname><given-names>RM</given-names></name>. <article-title>Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model</article-title>. <source>Infect Immun</source>. <year>2004</year>;<volume>72</volume>: <fpage>4911</fpage>&#x2013;<lpage>4917</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.72.8.4911-4917.2004</pub-id>
<pub-id pub-id-type="pmid">15271960</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref044">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>de Jong</surname><given-names>MF</given-names></name>, <name><surname>Tsolis</surname><given-names>RM</given-names></name>. <article-title>Brucellosis and type IV secretion</article-title>. <source>Future Microbiol</source>. <year>2012</year>;<volume>1</volume>: <fpage>47</fpage>&#x2013;<lpage>58</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2217/fmb.11.136</pub-id>
<pub-id pub-id-type="pmid">22191446</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref045">
        <label>45</label>
        <mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>YH</given-names></name>, <name><surname>Rol&#xE1;n</surname><given-names>HG</given-names></name>, <name><surname>Den Hartigh</surname><given-names>AB</given-names></name>, <name><surname>Sondervan</surname><given-names>D</given-names></name>, <name><surname>Tsolis</surname><given-names>RM</given-names></name>. <article-title>Brucella abortus VirB12 is expressed during infection but is not an essential component of the type IV secretion system</article-title>. <source>Infect Immun</source>. <year>2005</year>;<volume>73</volume>: <fpage>6048</fpage>&#x2013;<lpage>6054</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.73.9.6048-6054.2005</pub-id>
<pub-id pub-id-type="pmid">16113325</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref046">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>Barbier</surname><given-names>T</given-names></name>, <name><surname>Z&#xFA;&#xF1;iga-Ripa</surname><given-names>A</given-names></name>, <name><surname>Moussa</surname><given-names>S</given-names></name>, <name><surname>Plovier</surname><given-names>H</given-names></name>, <name><surname>Sternon</surname><given-names>JF</given-names></name>, <name><surname>L&#xE1;zaro-Ant&#xF3;n</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Brucella central carbon metabolism: an update</article-title>. <source>Crit Rev Microbiol</source>. <year>2018</year>;<volume>44</volume>: <fpage>182</fpage>&#x2013;<lpage>211</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/1040841X.2017.1332002</pub-id>
<pub-id pub-id-type="pmid">28604247</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref047">
        <label>47</label>
        <mixed-citation publication-type="journal"><name><surname>MacHelart</surname><given-names>A</given-names></name>, <name><surname>Willemart</surname><given-names>K</given-names></name>, <name><surname>Z&#xFA;&#xF1;iga-Ripa</surname><given-names>A</given-names></name>, <name><surname>Godard</surname><given-names>T</given-names></name>, <name><surname>Plovier</surname><given-names>H</given-names></name>, <name><surname>Wittmann</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Convergent evolution of zoonotic Brucella species toward the selective use of the pentose phosphate pathway</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2020</year>;<volume>117</volume>: <fpage>26374</fpage>&#x2013;<lpage>26381</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.2008939117</pub-id>
<pub-id pub-id-type="pmid">33020286</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref048">
        <label>48</label>
        <mixed-citation publication-type="journal"><name><surname>Z&#xFA;&#xF1;iga-Ripa</surname><given-names>A</given-names></name>, <name><surname>Barbier</surname><given-names>T</given-names></name>, <name><surname>L&#xE1;zaro-Ant&#xF3;n</surname><given-names>L</given-names></name>, <name><surname>de Miguel</surname><given-names>MJ</given-names></name>, <name><surname>Conde-&#xE1;lvarez</surname><given-names>R</given-names></name>, <name><surname>Mu&#xF1;oz</surname><given-names>PM</given-names></name>, <etal>et al</etal>. <article-title>The fast-growing Brucella suis Biovar 5 depends on phosphoenolpyruvate carboxykinase and pyruvate phosphate dikinase but not on Fbp and GlpX fructose-1,6-bisphosphatases or isocitrate lyase for full virulence in laboratory models</article-title>. <source>Front Microbiol</source>. <year>2018</year>;<volume>9</volume>: <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fmicb.2018.00641</pub-id>
<pub-id pub-id-type="pmid">29403456</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref049">
        <label>49</label>
        <mixed-citation publication-type="journal"><name><surname>Z&#xFA;&#xF1;iga-Ripa</surname><given-names>A</given-names></name>, <name><surname>Barbier</surname><given-names>T</given-names></name>, <name><surname>Conde-&#xC1;lvarez</surname><given-names>R</given-names></name>, <name><surname>Mart&#xED;nez-G&#xF3;mez</surname><given-names>E</given-names></name>, <name><surname>Palacios-Chaves</surname><given-names>L</given-names></name>, <name><surname>Gil-Ram&#xED;rez</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Brucella abortus depends on pyruvate phosphate dikinase and malic enzyme but not on fbp and glpX fructose-1,6-bisphosphatases for full virulence in laboratory models</article-title>. <source>J Bacteriol</source>. <year>2014</year>;<volume>196</volume>: <fpage>3045</fpage>&#x2013;<lpage>3057</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JB.01663-14</pub-id>
<pub-id pub-id-type="pmid">24936050</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref050">
        <label>50</label>
        <mixed-citation publication-type="journal"><name><surname>Maloy</surname><given-names>SR</given-names></name>, <name><surname>Bohlander</surname><given-names>M</given-names></name>, <name><surname>Nunn</surname><given-names>WD</given-names></name>. <article-title>Elevated levels of glyoxylate shunt enzymes in Escherichia coli strains constitutive for fatty acid degradation</article-title>. <source>J Bacteriol</source>. <year>1980</year>;<volume>143</volume>: <fpage>720</fpage>&#x2013;<lpage>725</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/jb.143.2.720-725.1980</pub-id>
<pub-id pub-id-type="pmid">7009561</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref051">
        <label>51</label>
        <mixed-citation publication-type="journal"><name><surname>K&#xF6;hler</surname><given-names>S</given-names></name>, <name><surname>Foulongne</surname><given-names>V</given-names></name>, <name><surname>Ouahrani-Bettache</surname><given-names>S</given-names></name>, <name><surname>Bourg</surname><given-names>G</given-names></name>, <name><surname>Teyssier</surname><given-names>J</given-names></name>, <name><surname>Ramuz</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>: <fpage>15711</fpage>&#x2013;<lpage>15716</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.232454299</pub-id>
<pub-id pub-id-type="pmid">12438693</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref052">
        <label>52</label>
        <mixed-citation publication-type="journal"><name><surname>Hong</surname><given-names>PC</given-names></name>, <name><surname>Tsolis</surname><given-names>RM</given-names></name>, <name><surname>Ficht</surname><given-names>TA</given-names></name>. <article-title>Identification of genes required for chronic persistence of Brucella abortus in mice</article-title>. <source>Infect Immun</source>. <year>2000</year>;<volume>68</volume>: <fpage>4102</fpage>&#x2013;<lpage>4107</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.68.7.4102-4107.2000</pub-id>
<pub-id pub-id-type="pmid">10858227</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref053">
        <label>53</label>
        <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>Q</given-names></name>, <name><surname>Pei</surname><given-names>J</given-names></name>, <name><surname>Turse</surname><given-names>C</given-names></name>, <name><surname>Ficht</surname><given-names>TA</given-names></name>. <article-title>Mariner mutagenesis of Brucella melitensis reveals genes with previously uncharacterized roles in virulence and survival</article-title>. <source>BMC Microbiol</source>. <year>2006</year>;<volume>6</volume>: <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2180-6-102</pub-id>
<pub-id pub-id-type="pmid">16401340</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref054">
        <label>54</label>
        <mixed-citation publication-type="book"><name><surname>Gottschalk</surname><given-names>G.</given-names></name>
<source>Bacterial Metabolism</source>. <edition designator="2">2nd Editio</edition>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>; <year>1986</year>.</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref055">
        <label>55</label>
        <mixed-citation publication-type="journal"><name><surname>Lacey</surname><given-names>CA</given-names></name>, <name><surname>Ponzilacqua-Silva</surname><given-names>B</given-names></name>, <name><surname>Chambers</surname><given-names>CA</given-names></name>, <name><surname>Dadelahi</surname><given-names>AS</given-names></name>, <name><surname>Skyberg</surname><given-names>JA</given-names></name>. <article-title>MyD88-Dependent Glucose Restriction and Itaconate Production Control Brucella Infection</article-title>. <source>Infect Immun</source>. <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.00156-21</pub-id>
<pub-id pub-id-type="pmid">34125603</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref056">
        <label>56</label>
        <mixed-citation publication-type="journal"><name><surname>Watford</surname><given-names>M</given-names></name>. <article-title>Glutamine and glutamate: Nonessential or essential amino acids?</article-title>
<source>Anim Nutr</source>. <year>2015</year>;<volume>1</volume>: <fpage>119</fpage>&#x2013;<lpage>122</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.aninu.2015.08.008</pub-id>
<pub-id pub-id-type="pmid">29767158</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref057">
        <label>57</label>
        <mixed-citation publication-type="journal"><name><surname>Tullius</surname><given-names>M V.</given-names></name>, <name><surname>Harth</surname><given-names>G</given-names></name>, <name><surname>Horwitz</surname><given-names>MA</given-names></name>. <article-title>Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs</article-title>. <source>Infect Immun</source>. <year>2003</year>;<volume>71</volume>: <fpage>3927</fpage>&#x2013;<lpage>3936</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.71.7.3927-3936.2003</pub-id>
<pub-id pub-id-type="pmid">12819079</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref058">
        <label>58</label>
        <mixed-citation publication-type="journal"><name><surname>Anand</surname><given-names>R</given-names></name>, <name><surname>Hoskins</surname><given-names>AA</given-names></name>, <name><surname>Bennett</surname><given-names>EM</given-names></name>, <name><surname>Sintchak</surname><given-names>MD</given-names></name>, <name><surname>Stubbe</surname><given-names>JA</given-names></name>, <name><surname>Ealick</surname><given-names>SE</given-names></name>. <article-title>A model for the Bacillus subtilis formylglycinamide ribonucleotide amidotransferase multiprotein complex</article-title>. <source>Biochemistry</source>. <year>2004</year>;<volume>43</volume>: <fpage>10343</fpage>&#x2013;<lpage>10352</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/bi0491292</pub-id>
<pub-id pub-id-type="pmid">15301532</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref059">
        <label>59</label>
        <mixed-citation publication-type="journal"><name><surname>Feehily</surname><given-names>C</given-names></name>, <name><surname>Karatzas</surname><given-names>KAG</given-names></name>. <article-title>Role of glutamate metabolism in bacterial responses towards acid and other stresses</article-title>. <source>J Appl Microbiol</source>. <year>2013</year>;<volume>114</volume>: <fpage>11</fpage>&#x2013;<lpage>24</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05434.x</pub-id>
<pub-id pub-id-type="pmid">22924898</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref060">
        <label>60</label>
        <mixed-citation publication-type="journal"><name><surname>Damiano</surname><given-names>MA</given-names></name>, <name><surname>Bastianelli</surname><given-names>D</given-names></name>, <name><surname>Al Dahouk</surname><given-names>S</given-names></name>, <name><surname>K&#xF6;hler</surname><given-names>S</given-names></name>, <name><surname>Cloeckaert</surname><given-names>A</given-names></name>, <name><surname>de Biase</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Glutamate decarboxylase-dependent acid resistance in Brucella spp.: Distribution and contribution to fitness under extremely acidic conditions</article-title>. <source>Appl Environ Microbiol</source>. <year>2015</year>;<volume>81</volume>: <fpage>578</fpage>&#x2013;<lpage>586</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/AEM.02928-14</pub-id>
<pub-id pub-id-type="pmid">25381237</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref061">
        <label>61</label>
        <mixed-citation publication-type="journal"><name><surname>Lott</surname><given-names>J. Shaun</given-names></name>
<article-title>The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease</article-title>. <source>Biochem Soc Trans</source>. <year>2020</year>;<volume>48</volume>: <fpage>2029</fpage>&#x2013;<lpage>2037</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1042/BST20200194</pub-id>
<pub-id pub-id-type="pmid">32915193</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref062">
        <label>62</label>
        <mixed-citation publication-type="journal"><name><surname>Kerrinnes</surname><given-names>T</given-names></name>, <name><surname>Young</surname><given-names>BM</given-names></name>, <name><surname>Leon</surname><given-names>C</given-names></name>, <name><surname>Roux</surname><given-names>CM</given-names></name>, <name><surname>Tran</surname><given-names>L</given-names></name>, <name><surname>Atluri</surname><given-names>VL</given-names></name>, <etal>et al</etal>. <article-title>Phospholipase A1 modulates the cell envelope phospholipid content of brucella melitensis, contributing to polymyxin resistance and pathogenicity</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2015</year>;<volume>59</volume>: <fpage>6717</fpage>&#x2013;<lpage>6724</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/AAC.00792-15</pub-id>
<pub-id pub-id-type="pmid">26282427</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref063">
        <label>63</label>
        <mixed-citation publication-type="journal"><name><surname>Clapp</surname><given-names>B</given-names></name>, <name><surname>Skyberg</surname><given-names>JA</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Thornburg</surname><given-names>T</given-names></name>, <name><surname>Walters</surname><given-names>N</given-names></name>, <name><surname>Pascual</surname><given-names>W</given-names></name> pascual. <article-title>Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses</article-title>. <source>Infect Immun</source>. <year>2011</year>;<volume>79</volume>: <fpage>4165</fpage>&#x2013;<lpage>4174</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.05080-11</pub-id>
<pub-id pub-id-type="pmid">21768283</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref064">
        <label>64</label>
        <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Becker</surname><given-names>T</given-names></name>, <name><surname>Walters</surname><given-names>N</given-names></name>, <name><surname>Pascual</surname><given-names>DW</given-names></name>. <article-title>Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge</article-title>. <source>Infect Immun</source>. <year>2006</year>;<volume>74</volume>: <fpage>3874</fpage>&#x2013;<lpage>3879</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.01957-05</pub-id>
<pub-id pub-id-type="pmid">16790759</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref065">
        <label>65</label>
        <mixed-citation publication-type="journal"><name><surname>Fisher</surname><given-names>SL</given-names></name>. <article-title>Glutamate racemase as a target for drug discovery</article-title>. <source>Microb Biotechnol</source>. <year>2008</year>;<volume>1</volume>: <fpage>345</fpage>&#x2013;<lpage>360</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1751-7915.2008.00031.x</pub-id>
<pub-id pub-id-type="pmid">21261855</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref066">
        <label>66</label>
        <mixed-citation publication-type="journal"><name><surname>Doublet</surname><given-names>P</given-names></name>, <name><surname>Van Heijenoort</surname><given-names>J</given-names></name>, <name><surname>Bohin</surname><given-names>JP</given-names></name>, <name><surname>Mengin-Lecreulx</surname><given-names>D</given-names></name>. <article-title>The murI gene of Escherichia coli is an essential gene that encodes a glutamate racemase activity</article-title>. <source>J Bacteriol</source>. <year>1993</year>;<volume>175</volume>: <fpage>2970</fpage>&#x2013;<lpage>2979</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/jb.175.10.2970-2979.1993</pub-id>
<pub-id pub-id-type="pmid">8098327</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref067">
        <label>67</label>
        <mixed-citation publication-type="journal"><name><surname>Morayya</surname><given-names>S</given-names></name>, <name><surname>Awasthy</surname><given-names>D</given-names></name>, <name><surname>Yadav</surname><given-names>R</given-names></name>, <name><surname>Ambady</surname><given-names>A</given-names></name>, <name><surname>Sharma</surname><given-names>U</given-names></name>. <article-title>Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosis</article-title>. <source>Gene</source>. <year>2015</year>;<volume>555</volume>: <fpage>269</fpage>&#x2013;<lpage>276</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.gene.2014.11.017</pub-id>
<pub-id pub-id-type="pmid">25447907</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref068">
        <label>68</label>
        <mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>B</given-names></name>, <name><surname>Jiang</surname><given-names>YJ</given-names></name>, <name><surname>Man</surname><given-names>MQ</given-names></name>, <name><surname>Brown</surname><given-names>B</given-names></name>, <name><surname>Elias</surname><given-names>PM</given-names></name>, <name><surname>Feingold</surname><given-names>KR</given-names></name>. <article-title>Expression and regulation of 1-acyl-sn-glycerol-3-phosphate acyltransferases in the epidermis</article-title>. <source>J Lipid Res</source>. <year>2005</year>;<volume>46</volume>: <fpage>2448</fpage>&#x2013;<lpage>2457</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1194/jlr.M500258-JLR200</pub-id>
<pub-id pub-id-type="pmid">16150824</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref069">
        <label>69</label>
        <mixed-citation publication-type="journal"><name><surname>Abrahams</surname><given-names>KA</given-names></name>, <name><surname>Cox</surname><given-names>JAG</given-names></name>, <name><surname>F&#xFC;tterer</surname><given-names>K</given-names></name>, <name><surname>Rullas</surname><given-names>J</given-names></name>, <name><surname>Ortega-Muro</surname><given-names>F</given-names></name>, <name><surname>Loman</surname><given-names>NJ</given-names></name>, <etal>et al</etal>. <article-title>Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>: <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-017-09642-y</pub-id>
<pub-id pub-id-type="pmid">28127051</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref070">
        <label>70</label>
        <mixed-citation publication-type="journal"><name><surname>Verger</surname><given-names>JM</given-names></name>, <name><surname>Grayon</surname><given-names>M</given-names></name>, <name><surname>Chaslus-Dancla</surname><given-names>E</given-names></name>, <name><surname>Meurisse</surname><given-names>M</given-names></name>, <name><surname>Lafont</surname><given-names>JP</given-names></name>. <article-title>Conjugative transfer and in vitro/in vivo stability of the broad-host-range IncP R751 plasmid in brucella spp</article-title>. <source>Plasmid</source>. <year>1993</year>;<volume>29</volume>: <fpage>142</fpage>&#x2013;<lpage>146</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1006/plas.1993.1016</pub-id>
<pub-id pub-id-type="pmid">8469720</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref071">
        <label>71</label>
        <mixed-citation publication-type="journal"><name><surname>Casadaban</surname><given-names>MJ</given-names></name>, <name><surname>Cohen</surname><given-names>SN</given-names></name>. <article-title>Analysis of Gene Control Signals by DNA Fusion and Cloning in Escherichia coli</article-title>. <source>J Mol Biol</source>. <year>1980</year>;<volume>138</volume>: <fpage>179</fpage>&#x2013;<lpage>207</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0022-2836(80)90283-1</pub-id>
<pub-id pub-id-type="pmid">6997493</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref072">
        <label>72</label>
        <mixed-citation publication-type="journal"><name><surname>Ouahrani-bettache</surname><given-names>S</given-names></name>, <name><surname>Porte</surname><given-names>F</given-names></name>, <name><surname>Teyssier</surname><given-names>J</given-names></name>, <name><surname>Liautard</surname><given-names>J</given-names></name>, <name><surname>K&#xF6;hler</surname><given-names>S</given-names></name>. <article-title>pBBR1-GFP: A Broad- Host-Range Vector for Prokaryotic Promoter Studies</article-title>. <source>Biotechniques</source>. <year>1999</year>;<volume>26</volume>: <fpage>620</fpage>&#x2013;<lpage>622</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2144/99264bm05</pub-id>
<pub-id pub-id-type="pmid">10343896</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref073">
        <label>73</label>
        <mixed-citation publication-type="journal"><name><surname>Sternon</surname><given-names>J</given-names></name>, <name><surname>Godessart</surname><given-names>P</given-names></name>, <name><surname>Gon&#xE7;alves de Freitas</surname><given-names>R</given-names></name>, <name><surname>Van der Henst</surname><given-names>M</given-names></name>, <name><surname>Poncin</surname><given-names>K</given-names></name>, <name><surname>Francis</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Transposon Sequencing of Brucella abortus Uncovers Essential Genes for Growth In Vitro and Inside Macrophages</article-title>. <source>Infect Immun</source>. <year>2018</year>;<volume>86</volume>: <fpage>1</fpage>&#x2013;<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/IAI.00312-18</pub-id>
<pub-id pub-id-type="pmid">29844240</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref074">
        <label>74</label>
        <mixed-citation publication-type="journal"><name><surname>Lestrate</surname><given-names>P</given-names></name>, <name><surname>Delrue</surname><given-names>R</given-names></name>, <name><surname>Danese</surname><given-names>I</given-names></name>, <name><surname>Didembourg</surname><given-names>C</given-names></name>, <name><surname>Taminiau</surname><given-names>B</given-names></name>, <name><surname>Mertens</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Identification and characterization of in vivo attenuated mutants of Brucella melitensis</article-title>. <source>Mol Microbiol</source>. <year>2000</year>;<volume>38</volume>: <fpage>543</fpage>&#x2013;<lpage>551</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.02150.x</pub-id>
<pub-id pub-id-type="pmid">11069678</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref075">
        <label>75</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Durbin</surname><given-names>R</given-names></name>. <article-title>Fast and accurate short read alignment with Burrows&#x2013;Wheeler transform</article-title>. <source>Bioinformatics</source>. <year>2009</year>;<volume>25</volume>: <fpage>1754</fpage>&#x2013;<lpage>1760</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
<pub-id pub-id-type="pmid">19451168</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref076">
        <label>76</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Handsaker</surname><given-names>B</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>Ruan</surname><given-names>J</given-names></name>, <name><surname>Homer</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>The Sequence Alignment / Map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>;<volume>25</volume>: <fpage>2078</fpage>&#x2013;<lpage>2079</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<pub-id pub-id-type="pmid">19505943</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref077">
        <label>77</label>
        <mixed-citation publication-type="journal"><name><surname>Finan</surname><given-names>TM</given-names></name>, <name><surname>Kunkel</surname><given-names>B</given-names></name>, <name><surname>De Vos</surname><given-names>GF</given-names></name>, <name><surname>Signer</surname><given-names>ER</given-names></name>. <article-title>Second symbiotic megaplasmid in Rhizobium meliloti carrying exopolysaccharide and thiamine synthesis genes</article-title>. <source>J Bacteriol</source>. <year>1986</year>;<volume>167</volume>: <fpage>66</fpage>&#x2013;<lpage>72</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/jb.167.1.66-72.1986</pub-id>
<pub-id pub-id-type="pmid">3013840</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref078">
        <label>78</label>
        <mixed-citation publication-type="journal"><name><surname>Deghelt</surname><given-names>M</given-names></name>, <name><surname>Mullier</surname><given-names>C</given-names></name>, <name><surname>Sternon</surname><given-names>J-F</given-names></name>, <name><surname>Francis</surname><given-names>N</given-names></name>, <name><surname>Laloux</surname><given-names>G</given-names></name>, <name><surname>Dotreppe</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>G1-arrested newborn cells are the predominant infectious form of the pathogen Brucella abortus</article-title>. <source>Nat Commun</source>. <year>2014</year>;<volume>5</volume>: <fpage>4366</fpage>. Available: <ext-link xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25006695" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/pubmed/25006695</ext-link>
<comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ncomms5366</pub-id>
<pub-id pub-id-type="pmid">25006695</pub-id>
</mixed-citation>
      </ref>
      <ref id="ppat.1012459.ref079">
        <label>79</label>
        <mixed-citation publication-type="journal"><name><surname>Shaner</surname><given-names>NC</given-names></name>, <name><surname>Campbell</surname><given-names>RE</given-names></name>, <name><surname>Steinbach</surname><given-names>PA</given-names></name>, <name><surname>Giepmans</surname><given-names>BNG</given-names></name>, <name><surname>Palmer</surname><given-names>AE</given-names></name>, <name><surname>Tsien</surname><given-names>RY</given-names></name>. <article-title>Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein</article-title>. <source>Nature biotechnology</source>. <year>2004</year>. pp. <fpage>1567</fpage>&#x2013;<lpage>1572</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nbt1037</pub-id>
<pub-id pub-id-type="pmid">15558047</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>